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Abstract
Nowadays, mass spectrometry is very important and widely applied tool in nucleo‐
tide analysis. As a result of technological advances in sample preparation, separation 
and mass spectrometry detection, the developed methods allow sensitive and selective 
measurement of polar compounds occurring in low levels in various biological matri‐
ces. This enables more potential uses in clinical field. Direct methods require no special 
sample pre‐treatment before analysis in contrast to indirect methods, where fraction‐
ation, dephosphorylation and purification are needed. The use of ion‐pairing agent, 
ion exchange chromatography with pH gradient, porous graphitic carbon columns and 
HILIC in liquid chromatography represents the most common methods of nucleotide 
analysis. High separation efficiency is also achieved with the use of CE with MS detec‐
tion. Analysis of nucleotides was also described by the means of MALDI‐TOF, but poor 
reproducibility and lack of applications make a limitation for this approach. The chap‐
ter summarizes different techniques and approaches for determination of endogenous 
nucleotides and its analogues in various clinical applications.
Keywords: nucleotides, nucleotide analogues, mass spectrometry, capillary electrophoresis, 
liquid chromatography, MALDI‐TOF, HILIC‐MS/MS, triple quadrupole, selected reaction 
monitoring
1. Introduction
Nucleotides and nucleosides, together with their deoxidized forms, are involved in  several 
important cellular processes. The structure of the nucleoside molecule consists of a  heterocyclic 
base (adenine, guanine, cytosine, uracil and thymine) joined to a molecule of pentose (ribose 
© 2017 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
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or deoxyribose) through a glycosidic bond. Nucleotides are formed by  phosphorylation of 
nucleoside molecule. They represent a fundamental building block of the structure of nucleic 
acids formed by the polymerase‐mediated synthesis of DNA and RNA from deoxynucleotides 
and nucleotides, respectively. All deoxynucleotides are synthesized from the corresponding 
nucleotides. Nucleotides play another important role in enzyme  activation and metabolism. 
They are incorporated into important cofactors of enzymatic reactions such as transfer of vari‐
ous groups by coenzyme A (e.g. acetyl‐CoA and succinyl‐CoA) in many metabolic processes, 
NAD, NADP and FAD as coenzymes of oxidoreductases catalyses redox reactions in the cell. 
ATP and other nucleoside triphosphates are engaged as source energy providers. In the form 
of coenzymes, they transfer phosphate residues or nucleotide  constituent and participate in 
the activation (e.g. uridine diphosphate glucose for pasting glucose units to polymeric saccha‐
rides or cytidine diphosphate‐choline for phospholipid synthesis). Cyclic nucleotides act as 
secondary messengers in many signal transduction pathways. The most important nucleotide 
signal molecule is cyclic adenosine monophosphate (cAMP), which is an activator of protein 
kinases and participates in many metabolic pathways by transferring the effect of hormones 
into cells. Analogical molecule—cyclic guanosine monophosphate (cGMP)—also acts as a sec‐
ondary messenger in the phototransduction process.
Nucleotide metabolism is one of the main therapeutic cellular targets. Synthetic analogues of 
these compounds have been widely applied in anti‐cancer, anti‐viral and immunosuppres‐
sive therapies [1–6]. Nucleoside analogues (e.g. cytarabine, gemcitabine and zidovudine) are 
modified at the base or sugar moiety. This ‘prodrug’ form requires intracellular activation 
by phosphorylation to mono, di or triphosphates. Related drugs are nucleobase analogues 
(6‐mercaptopurine and thioguanine) without sugar‐phosphate moiety and also fluoropyrimi‐
dines (fluorouracil, capecitabine and floxuridine). Its mechanism of action is based on the 
structural similarity to its natural endogenous precursor. Therefore, the analogues are called 
‘anti‐metabolites’ [4, 7].
Over 30 inherited disorders resulting from errors of purine and pyrimidine metabolism are 
known, and therefore the determination of the levels of nucleosides and nucleotides is used 
in their diagnosis and treatment monitoring. Disorders of purine and pyrimidine metabo‐
lism are clinically very diverse—manifestations include immunodeficiencies, urolithiases, 
mental defects and others. Adenosine deaminase deficiency, resulting in deoxyadenosine 
 accumulation; purine nucleoside phosphorylase deficiency, characterized by elevated deox‐
yguanosine; hyperuricemia; hypoxanthine‐guanine phosphoribosyl transferase deficiency, 
leading to high levels of uric acid, and phosphoribosylpyrophosphate synthetase overactiv‐
ity, resulting in the overproduction of purine and uric acid. The most common pyrimidine 
metabolism disorder is orotic aciduria, where the defect of UMP‐synthase causes the disease 
and leads to the excessive excretion of orotic acid in the urine [8].
Similarly, the determination of nucleotides and their intermediates is an important tool for 
understanding the metabolism of endogenous nucleotides and their synthetic analogues 
and also for the establishment of a diagnosis of disorders related to defects in the biosyn‐
thesis and degradation processes of purine/pyrimidine nucleotides [9]. The concentration 
of  particular deoxy/nucleotides differs among various cell types and extracellular material 
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(plasma, urine—very low concentrations are physiologically present). Intracellular nucleo‐
tide analogue levels can also vary from patient to patient, which can result in under‐treat‐
ment or toxicities [10]. In consequence of the often very low intracellular levels of nucleotide 
analogues in comparison to their natural variants, highly sensitive and selective analytical 
methods are necessary for the quantification [9–11].
Sample preparation is the major critical step in the determination of endogenous nucleotides 
and their analogues in biological material. The pre‐analytical phase, including sampling, 
transport of material and sample preparation, plays an important role in the whole analyti‐
cal process. The treatment of the sample is based on the material used for analysis, such as 
whole blood [12], erythrocytes [13–15], mononuclear cells [14, 16–24], cultured cells [25–35], 
plasma [12, 19, 20, 36, 37], urine [38], dry blood spots [15] and others [36, 39–47]. The enzymes 
involved in purine and pyrimidine metabolism can fundamentally change the nucleotide 
pool during the pre‐analytical process and this should be stopped as soon as possible.
To date, many and various approaches using different analytical techniques have been 
 developed for the determination of nucleotides and their analogues (in this chapter  globally 
called nucleotides). Historically, the ATP concentration was measured by means of the 
 luciferin‐luciferase luminescence assay technique [48]. Radioimmunoassays were quite sensi‐
tive but had poor specificity as a result of cross‐reactivity with structurally similar molecules 
[49, 50]. For separation of nucleotides, thin layer chromatography [51], capillary electropho‐
resis (CE) [52–56] and liquid chromatography [9, 12–15, 18, 19, 29, 30, 32, 36, 40, 42, 45, 46, 
57–62] have been used. Because of the requirement of the simultaneous determination of 
 several nucleotides and low‐level deoxynucleotides occurring in complex matrices, separa‐
tion techniques coupled predominantly to UV/DAD or mass spectrometry (MS) detection 
have become essential tool for analysis. Although UV detection has been widely applied for 
the detection of nucleotides in biological matrix [63–72], it suffers from very low sensitivity 
and specificity [9]. Sensitivity for adenosine nucleotides was significantly improved by fluores‐
cence detection. However, analysis by means of this approach is time‐consuming as a result 
of required derivatization step [73].
The first application of mass spectrometry to the analysis of amino acids and peptides was 
reported in 1958 [74]. With the advent of clinically useful mass spectrometers, this technology 
prevails for nucleotide detection in biological matrices. Because of the increasing require‐
ments of clinical laboratories to analyse multiple analytes in a broad concentration range 
simultaneously, the high sensitivity and specificity of the technique and its growing price 
availability, it has become a prominent tool in most clinical research and routine practice.
Capillary electrophoresis (CE) can be used for the separation of mainly ionic and highly 
polar compounds with high resolution, which makes this technique suitable for nucleotide 
 analysis. In combination with mass spectrometry, it has been used for nucleotide analysis in 
several applications [10, 52, 53, 55, 56, 75]. However, the most crucial problem in the coupling 
of CE to MS detection is the limited range of available and convenient interface techniques. 
Moreover, the electrophoresis run buffer has to be compatible with MS detection. Because 
of the  practicality and wide possibilities of adjustment, presently liquid chromatography in 
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combination with mass spectrometry is the most frequently used separation technique for 
nucleotide determination in many biological materials.
Liquid chromatography has become an essential tool for the analysis of nucleotide in recent 
decades. The polarity of the nucleotides increases with the number of phosphate groups. 
Reversed‐phase (RP) liquid chromatography is frequently used for the separation of nucle‐
osides and also nucleoside monophosphates [14, 15, 22, 28, 30, 33, 36, 37, 58]. Because of 
their hydrophilicity, triphosphate nucleosides have very poor retention when separated 
on  traditional reverse‐phase high‐performance liquid chromatography columns, and thus 
another chromatographic approach is required. The possibility is using ion‐pairing [12, 16, 
19–21, 23, 26, 31, 32, 41, 47] or anion exchange chromatography [13, 17, 18, 27, 42]. These 
approaches enhance the retention on RP columns, but they are, however, compromised by 
the high levels of additives in mobile phases (ammonium salts and alkylamines), which cause 
significant ion suppression, poor robustness and instability of the ion exchange columns, and 
also source pollution, which remains a major problem [10, 16, 60, 76]. The analysis of nucleo‐
tides on RP‐HPLC is also possible by indirect methods based mainly on dephosphorylation 
using uric acid or alkaline phosphatase and subsequent analysis of particular nucleosides, 
the retention of which is significantly better on reverse‐phase analytical columns compared 
to their triphosphate precursors [14, 15, 22, 33, 77, 78]. The indirect methods using fraction‐
ation and dephosphorylation simplify the final determination of significantly better ioniz‐
able  nucleosides, but the overall complexity and time required for the use of the method 
rises and many errors could be introduced into the sample pre‐treatment. Another possible 
way to measure nucleosides and their monophosphates (MP), diphosphates (DP) and triphos‐
phates (TP) by liquid chromatography under MS‐friendly conditions is using hydrophilic 
 interaction liquid chromatography. Polar columns using mobile phase rich in organic solvent 
with increasing amount of water content during analytical run are suitable for coupling with 
MS [34, 39, 40, 43, 79].
In the last decade, many reviews on the analysis of endogenous nucleotides and low‐level 
nucleotide analogues in biological matrices by various separation techniques but especially 
with liquid chromatography [9] and detection by mass spectrometry [10, 11] have been pub‐
lished. This chapter is focused on describing several approaches to the determination of 
endogenous nucleotides and low‐level nucleotide analogues in biological matrices by means 
of various separation techniques in combination with mass spectrometry detection. In practi‐
cal part, we are showing analysis of low‐level of nucleotide analogues 5′‐ethynyl‐2′‐deoxy‐
cytidine and 5′‐ethynyl‐2′‐deoxyuridine, their mono‐, di‐, and triphosphates in the presence 
of the high levels of the physiological nucleotides by LC‐MS/MS method.
2. Sample preparation
The sample preparation is probably the most critical step in separation methods. The mostly 
used mass spectrometers need a clean sample without salts and lipids causing ion suppres‐
sion, signal response reduction and poor robustness of analytical methods. Gradual pollution 
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of the ion source and other parts of the instrument causes poor analytical quality and harms 
the long‐term stability of the instrument. The pre‐treatment of the sample and extraction of 
the nucleotides depend on the matrix sample types, such as peripheral blood mononuclear 
cells (PBMCs), cultured cells, tissue, plasma and so on, and also on the separation and detec‐
tion mode. All matrices contain many active enzymes included in the biochemical pathways 
responsible for the conversions or transformations of nucleotides. Thus, cell lysis and inacti‐
vation of certain enzymes is the first required step. The extraction solution should therefore 
completely extract nucleotides and precipitate and inactivate proteins without compromis‐
ing the stability of these analytes. The nucleotide structure contains phosphate groups and 
therefore the compounds have ionic character. It must be taken into account that during the 
preparation of the sample the organic agents used for each step of the sample preparation 
have enough polarity to prevent precipitation of the nucleotides. It is different for mono‐, di‐, 
and triphosphates, with triphosphates especially being sensitive to the choice of less polar sol‐
vents. In general, the sample preparation is initiated by the protein precipitation and extrac‐
tion of the nucleotides, eventually purified from phospholipids by solid phase extraction 
(SPE) or liquid‐liquid extraction (LLE), pre‐concentrated by evaporating under the nitrogen 
flow or freeze drying and reconstituting in predominantly water solution.
Protein precipitation (PP) is usually performed with a strong acid such as perchloric acid 
(PCA) [17, 25, 36, 41, 62, 80] or trichloroacetic acid (TCA) [42, 75] and most often by organic 
solvents such as methanol (MetOH) [12, 18, 26–28, 39, 43, 55, 60, 81, 82] or ethanol (EtOH) [19] 
or acetonitrile (AcCN) [37]. Because of the instability of nucleotides at a low pH, a neutraliza‐
tion step after the PP with strong acid is required. Neutralization was performed using NaOH 
with a subsequent centrifugation step [80]. The PCA extracts were treated with KOH and 
the resulting KClO
4
 precipitate was removed by centrifugation. The supernatant was directly 
stored at −20°C [25] or lyophilized [41] prior to the LC‐MS analysis. The PP and extraction of 
the cyclic nucleotides by PCA was introduced in a study by Oeckl et al. and it was demon‐
strated on plasma and brain tissues. The materials were homogenized with 0.4 M PCA using 
sonication, and after centrifugation, the supernatant was filtered through cellulose membrane 
and stored at −80°C until analysis [36, 62].
PP with TCA is less frequently described because of its poor compatibility with MS detection; 
nevertheless Friedecký et al. used TCA for the deproteination of incubated cells followed by 
back‐extraction into ether. This procedure provided an increased pH value and better stability 
of the nucleotides. Water phase extracts were used for the CE‐MS analyses [75].
At present, precipitation by organic solvent is predominantly used. Derissen et al. described 
the usage of pure MetOH for the lysis of PBMC, and after mixing and centrifugation, the  sample 
extract was stored at −70°C until analysis [18]. MetOH was used for the PP of the plasma 
samples designed for the determination of the nucleotides [12]. Soga et al. also used MetOH 
for cell lysis, but this procedure was followed by LLE based on the addition of  chloroform and 
water to remove the phospholipids. After centrifugation, the resulting water‐MetOH layer 
was lyophilized and dissolved in pure water before CE‐ESI‐MS analysis [55]. In a general 
metabolomic study covering 164 compounds including several nucleotides, 80% MetOH at 
the temperature of 75°C was used for three consecutive metabolite extractions [43]. Cell lysis, 
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PP and nucleotide extraction were also performed with ice‐cold 70% MetOH [27, 39] followed 
by storage at −20°C [28, 82] or snap‐frozen in liquid nitrogen [29]. A similar procedure can be 
performed with a 60% MetOH solution followed by incubation at −20°C for complete extrac‐
tion and PP [26, 81] or frozen in liquid N
2
 [60]. In a study of rat heart tissue, the extraction 
of the homogenate was performed with pre‐cooled MetOH‐water (1:1, v/v) and followed by 
centrifugation, and the supernatant was directly analysed [45]. Cyclic intracellular nucleo‐
tides were extracted by a mixture of AcCN/MetOH/water (2:2:1, v/v). The extract was heated 
to 95°C, cooled down, centrifuged, dried under flow of nitrogen and resuspended in water 
for analysis [30].
Several studies compared extraction procedures. Klawitter et al. compared four extraction 
agents [12% PCA, 70% AcCN, 70% MetOH and MetOH/chloroform (1:1, v/v)] applied to 
homogenized kidney tissue. The extracted homogenates were centrifuged, and the superna‐
tant was collected, pellet was re‐suspended in water and centrifuged and the supernatants 
were combined. In case of the PCA extraction, an additional neutralizing step (2 M KOH 
followed by 1 M KHCO3) was performed. The resulting KClO4 precipitate was removed and extracts were consequently lyophilized. The PCA extraction provided the best absolute recov‐
ery and best reproducibility among the four extraction procedures used in this study. The 
recovery varied from 75.6 to 89.1%, depending on the type of nucleotide [41]. Cordell et al. 
compared extraction solvents such as AcCN, ethanol (EtOH), MetOH, AcCN:water (8:2, v/v), 
EtOH:water (8:2, v/v), MetOH:water (8:2, v/v), 0.1 M formic acid, 0.5 M PCA and 0.1 M formic 
acid in MetOH using Chinese hamster ovary (CHO) cells. The authors also studied the effect 
of sonication on ice prior to the removal of the extraction fluid as well as the hexane addition 
in the case of methanol extraction. Methanol cooled to −20°C offered the most efficient extrac‐
tion, with an average recovery of 53%. The addition of a hexane extraction step improves the 
sample clean‐up and peak shapes and removes many problems attributed to the phospho‐
lipids [31]. Derissen et al. tested four extraction agents: MetOH, EtOH, AcCN and 1.35 M 
PCA at different volume ratios. Finally, 100 μL of methanol added to the 60 μL of the PBMC 
suspension, followed by extensive vortex mixing and direct centrifugation according to the 
extraction procedure 1 provided the most favourable results [18].
Sample pre‐treatment by PP seems to be a suitable method for removing proteins and the 
extraction of nucleotides from biological samples. Since the concentration of some  nucleotide 
analogues is often very low, and further clean‐up procedures (ultrafiltration) and pre‐
concentration [solid phase extraction (SPE), LLE] are needed. Cordell et al. showed that 
 phospholipids can be removed from the sample by LLE by hexane [31]. A similar procedure 
was reported by Soga et al. using chloroform and water being added to a methanol extract of 
Escherichia coli culture to remove phospholipids liberated from the cell membranes [55]. An 
additional sample clean‐up was used in the study of Crauste et al., where cell extracts were 
purified by a weak anion exchange (WAX) SPE column after PP by MetOH. The mean extrac‐
tion recoveries were between 60 and 81%, depending on the analyte. The effect of ion sup‐
pression on the peaks before and after SPE was also compared and the results indicated that 
SPE extraction allows the matrix effect to be reduced [81]. An additional sample clean‐up with 
WAX‐SPE after PP was introduced in several studies [39, 42, 83]. Comparison of extraction 
efficiency in protein‐precipitated samples with and without consequent WAX SPE clean‐up 
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procedure was described by Kamčeva et al. Extraction recovery for the procedure without 
SPE was achieved in the range 59.2–91.9% and with SPE in the range from 94.2 to 121.8%. The 
lower recovery for the first method can be explained by higher ion suppression; however, the 
usage of isotope‐labelled triphosphates (ATP, GTP, UTP, dATP, dCTP, dGTP, dTTP) as inter‐
nal standards simplified the nucleotide extraction step. The analytes and their isotopically 
labelled standards are affected equally by the cell matrix and the interference originating from 
the cell matrix influencing the recovery is reduced. Thus, additional steps for sample clean‐up 
such as time‐consuming and expensive SPE were unnecessary [60]. Cell lysis, protein precipi‐
tation and nucleotides extraction can be also carried out by MetOH in combination with Tris‐
HCl buffer [16, 20]. Another cell sample treatment was introduced by Teleki et al. Biomasses 
of E. coli were quenched by liquid nitrogen, diluted to the defined extraction concentration, 
immediately pre‐incubated at 100°C with short‐time vortexing in a water bath for enzymatic 
inactivation and then chilled on ice water. The metabolite extracts were separated from the 
cell debris by centrifugation and stored at −70°C [40]. The analysis of the nucleotide content in 
red blood cells (RBC) is described in a study by Hofmann et al. RBC mixed with EDTA, dithio‐
threitol and IS were heated at 95°C in a water bath for protein denaturation. The samples were 
subsequently extracted by MetOH followed with dichloromethane. After centrifugation, the 
supernatant was used for LC‐MS/MS analysis [13].
Another procedure for sample clean‐up was reported. In a study of Klawitter et al. compar‐
ing four extraction procedures (see above), additional online desalting was applied. The final 
extracts were loaded onto a C18 cartridge desalting column and washed with dibutylam‐
monium formate buffer/methanol (95:5). Thereafter, the valve was switched back onto the 
analytical column. This switching procedure led to better reproducibility of the HPLC reten‐
tion times and significantly improved the stability of the electrospray (ESI) as a result of the 
lower amounts of salt precipitated in the spray chamber [41]. In a study by Wu et al., super‐
natant resulted from centrifugation after PP was additionally cleaned by ultrafiltration with 
a molecular weight cut‐off of 3000 Da [32]. According to Becher et al., Tris‐HCl/MetOH cell 
lysates were treated by immunoaffinity extraction [21].
Further study used ice‐cold MetOH and subsequent cell lysis by fast heating or using of sonic 
dismembrator for the islets of Langerhans and E. coli cells in MALDI‐TOF analysis. The sam‐
ples were mixed with matrix (9‐aminoacridine) and deposited onto a MALDI target plate 
using the dried‐droplet method [44]. In a study by van Kampen of AZT‐triphosphate and 
nucleotide triphosphates in PBMCs by the means of MALDI‐TOF technique, the pre‐treat‐
ment of the sample was also based on ice‐cold MetOH extraction followed by overnight incu‐
bation at 4°C, centrifugation, freeze drying and reconstitution. Before analysis, the sample 
was pipetted onto an Anchor Chip target plate, onto which the matrix had previously been 
applied and dried [84].
For indirect methods, where parental nucleoside resulting from the dephosphorylation of 
nucleotides is detected, the preparation of the sample is based on PP and the extraction of 
nucleotides from the matrix and subsequent fractionation of the sample to MP, DP and TP, 
usually by means of a salt gradient applied to an anion exchange SPE cartridge. Particular 
fractions are exposed to dephosphorylation on parent nucleosides, mostly by means of an 
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acid or alkaline phosphatase, eventually desalted and pre‐concentrated by additional SPE. 
Cells or other matrices were precipitated by the means of 70% aqueous MetOH and the 
extract was separated into MP, DP and TP fractions using strong anion exchange cartridge 
with a potassium chloride gradient. The resulted fractions were treated by acid [14, 22, 33, 59] 
or alkaline [15] phosphatase for dephosphorylation to parental nucleoside. After  hydrolysis, 
samples were desalted and purified by SPE and analysed. Preparation of the sample for indi‐
rect analysis is time and material consuming. Even if the final nucleoside analysis is quite 
simple, each sample fraction must be analysed separately. Each step in an indirect method 
could be the cause of a definite error resulting in inaccurate determination of the nucleotides.
In summary, sample preparation is the most important and critical step in the analysis of 
nucleotides. The proper extraction and clean‐up procedures depend on various matrices and 
separation and detection techniques and should be chosen carefully.
3. Capillary electrophoresis with mass spectrometry detection  
in analysis of nucleotides
Capillary electrophoresis (CE) is an analytical technique enabling the separation of  compounds 
in a fused silica capillary using electrolyte solution (separation buffer) under an electrical field 
application. Ionized molecules migrate through an electrolyte solution (separation buffer) 
under an electrical field application. In CE, cations migrate towards the cathode, whereas 
anions move in the opposite direction. Molecules migrate to the detector at different veloci‐
ties that are based on their electrophoretic mobilities. This depends on their charge and size, 
the pH buffer, ionic strength, buffer composition and viscosity. The next factor that signifi‐
cantly affects the electrophoretic migration and separation of analytes is the electro‐osmotic 
flow (EOF). The silica capillary surface is negatively charged under the alkaline  conditions 
resulting from the ionization of silanol groups. The EOF can be modified, inversed or deleted 
by covalent or dynamic capillary wall modifications using surfactants or neutral or ionized 
polymers.
Numerous modes in CE enable the separation of a wide spectrum of compounds and thanks 
to the different separation mechanisms that can provide complementary information. The 
most widely used is capillary zone electrophoresis (CZE), where the mobility of an analyte 
is a vector sum of its electrophoretic mobility and the electro‐osmotic mobility of the buffer. 
Micellar electrokinetic chromatography (MEKC) can be used for the separation of charged as 
well as neutral less polar compounds. The running buffer is enriched by surfactants forming 
micelles that can interact with neutral less polar compounds in a chromatographic manner 
through both hydrophobic and electrostatic interactions. CE can also be used with a capillary 
filled with different phases, resulting in different separation modes. A capillary filled with 
gel buffer enables the separation of molecules according to their size (capillary gel electro‐
phoresis, CGE) and is used mainly for macromolecules such as protein and DNA analysis. 
CE with a chromatographic stationary phase capillary filling, mixture of ampholytes creating 
a pH gradient in capillary and several running buffers with different conductivities is called 
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capillary electrochromatography (CEC), capillary isoelectric focusing (CIEF) and capillary 
isotachophoresis (ITP), respectively.
In the last three decades, CE represented the main technique for the direct determination 
of nucleotides. However, with the development of new stationary phases compatible with 
highly polar analytes, liquid chromatography plays a more important role in the analysis 
of nucleotides. Despite this fact, CE represents a valuable alternative to chromatographic 
techniques for nucleotide analysis. Separation is fast, with very high efficiency. Low solvent 
and sample consumption and low running costs represent other significant advantages in the 
application of the technique, especially in combination with mass spectrometry detection.
Several methods using CE‐MS have been developed for the determination of nucleotide 
 analogues in clinical applications. Cai et al. introduced a method for the simultaneous analy‐
sis of the nucleoside reverse transcriptase inhibitor (NRTI) Ziagen (Abacavir) and its phos‐
phorylated metabolites such as carbovir monophosphate, carbovir diphosphate and carbovir 
triphosphate that is used for the treatment of human immunodeficiency virus (HIV) type 1. 
This method enables the separation and detection of positively charged nucleoside analogues 
and negatively charged nucleotides in a single electrophoretic run thanks to the application of 
a time‐segment program. The linearity of the method was established in the range 2–100 μM and 
the limits of detection for all the analytes were less than 2 μM. The capability of the method 
was demonstrated on human PBMC extracts spiked with Ziagen and its phosphorylated 
metabolites at 20 μM levels. Some endogenous nucleotides, such as adenosine 5′‐triphosphate 
(ATP), adenosine 5′‐diphosphate (ADP) and adenosine 5′‐monophosphate (AMP), were also 
detected in the cellular extracts [53].
Liu et al. used CE‐ESI‐MS for the determination of 14 compounds, including antiretroviral 
dideoxynucleosides (ddN), their nucleotides and a set of endogenous ribonucleosides and 
ribonucleotides. Separation by means of CE was performed on an untreated column using 
a volatile background electrolyte for ESI‐MS. All the analytes were profiled within single 
18 min CZE run. The method was applied to detect natural nucleotides, lamivudine and its 
mono‐, di‐, and triphosphates in the human hepatoma cell line Hep G2 [56].
The conversion of 5‐amino‐4‐imidazolecarboxamide riboside (ZR) into mono‐, di‐, and tri‐
phosphates in human erythrocytes was demonstrated in a study by Friedecký et al. The eryth‐
rocytes were incubated with ZR in order to simulate the situation in the inherited metabolic 
disorder of the purine metabolism AICA‐ribosiduria. Characteristic AICA‐ribotides, together 
with the naturally occurring nucleotides AMP, ADP and ATP, were separated by means of 
capillary electrophoresis in an acetate buffer (20 mmol L−1, pH 4.4) and identified online by 
mass spectrometry in negative mode [75].
Bezy et al. introduced the CE‐ESI‐MS/MS method for the simultaneous measurement of 
nucleoside 5′‐triphosphate and 5′‐monophosphate anabolites of the anti‐HIV drugs, didano‐
sine (ddATP, ddAMP) and stavudine (d4T‐MP, d4T‐TP), among a pool of 14 endogenous 
5′‐mono‐, di‐ and triphosphate nucleosides in extracted PBMC. The running electrolyte con‐
sisted of an acetic acid/ammonia buffer with pH = 10 and ionic strength of 40 mM. Finally, the 
quantification of d4T‐TP and ddATP was validated in this CE‐MS/MS system [52].
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The simultaneous analysis of naturally occurring nucleotides, nicotinamide‐adenine dinu‐
cleotides and CoA compounds was introduced by Soga et al. using a pressure‐assisted CE‐
MS. The method allowed simultaneous analysis of various compounds and offered sufficient 
sensitivity and selectivity, reproducibility, robustness and linearity. The required reproduc‐
ibility of the system was achieved by exchanging the running electrolyte after every analy‐
sis using a buffer replenishment system. Under optimized conditions, 14 phosphorylated 
compounds were well determined in less than 20 min with detection limits between 0.5 and 
1.7 μM. The usefulness of the method is demonstrated through the analysis of intracellular 
nucleotides and CoA compounds extracted from E. coli wild‐type and pfkA and pfkB knock‐
out mutants [55].
The combination of CE‐enabling rapid analysis with efficient resolution and MS with excel‐
lent selectivity and sensitivity makes a very powerful technique for nucleotide analysis and a 
good alternative to the conventionally used LC‐MS technique. Nevertheless, the development 
of the method for the separation of the nucleotides by means of CE coupled with MS detection 
still represents a big challenge. The hyphenation of CE with MS is technically demanding. 
Moreover, the commonly used electrophoresis running buffers are not compatible with MS 
detection as a result of the high concentration of electrolytes, which may create high back‐
ground signals in ESI‐MS analyses.
4. Liquid chromatography‐mass spectrometry for the determination  
of nucleotides
Liquid chromatography (LC) is an analytical technique enabling very efficient and sensi‐
tive separation of compounds in complex sample matrices. The principle of the technique is 
based on the interactions and distribution of sample components between the stationary and 
mobile phase. The strength of the interaction determines the order of the elution of particular 
 analytes. Because of the requirement for better efficiency of separation and shorter analysis 
time, high‐performance liquid chromatography (HPLC) was investigated. The application of 
high pressure with a faster flow rate and separation columns with particles smaller than 2 μm 
offers highly efficient compound separation with a shorter analysis time in comparison to 
common column (low‐pressure) chromatography. Currently, most applications for the analy‐
sis of nucleotides are based on liquid chromatography coupled with tandem mass spectrom‐
etry, and therefore descriptions of approaches involving these represent a major part of this 
chapter.
The majority of polar analytes are separated using reversed‐phase high‐performance  liquid 
chromatography (RP‐HPLC), where the stationary phase is usually non‐polar [silica gel 
coated by octadecyl‐ (C18), octyl‐ (C8) or cyanogroup (CN)] and the mobile phase is com‐
posed of polar organic solvents (methanol or acetonitrile) in combination with a water buffer. 
The retention of compounds depends on hydrophobic interactions with the stationary phase. 
Using gradient elution, the polarity of the mobile phase is declined with a greater amount 
of organic solvent, resulting in the faster elution of non‐polar analytes from the column. The 
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polarity of nucleotides increases with the number of phosphate groups. In contrast to nucle‐
oside monophosphates (MP), nucleoside triphosphates (TP) and nucleoside diphosphates 
(DP) are therefore only minimally retained and are separated from other nucleotides on the 
commonly used reversed‐phase HPLC columns under traditional conditions with a typical 
aqueous‐organic mobile phase. In addition, many interferences from the matrix are poorly 
retained and the specificity and selectivity of the method is reduced even more. Introducing 
an ion‐pairing (IP) reagent or anion exchange (AX) chromatography enabled the usage of 
RP‐HPLC columns for the analysis of nucleotides. Although IP and AX chromatography are 
the most suitable methods for nucleotide analysis, high concentrations of a non‐volatile ion‐
pairing reagent and/or a high salt concentration preclude the use of mass spectrometry for 
detection. Therefore, the type and concentration of the ion‐pairing agent must be optimized. 
Moreover, the strong retention of ion‐pairing agents inside the mass spectrometer makes it 
impossible to use instrumentation for other methods because of the interference of the IP 
agents with the compounds being analysed.
4.1. Reversed‐phase liquid chromatography
As mentioned above, RP‐HPLC‐MS does not enable the analysis of nucleoside di‐ and tri‐
phosphates because of the low retention on the column. Therefore, RP‐HPLC in a common 
setting is acceptable for the determination of nucleotides by indirect methods. The methods 
are usually based on the separation of the sample extract into MP, DP and TP fractions and 
subsequent dephosphorylation with alkaline or acid phosphatases on nucleoside forms. 
Consequently, nucleosides can be determined in a common RP‐HPLC‐MS setting.
Rodriguez et al. developed an indirect method for the quantification of the intracellular 
NRTIs zidovudine (ZDV) and lamivudine (3TC) triphosphates in patients with HIV infection. 
Extracted peripheral blood mononuclear cells (PBMCs) were separated into MP, DP and TP 
fractions using strong anion‐exchange Sep‐Pak plus (SAX‐QMA) cartridges with a potassium 
chloride gradient. The cleavage of the phosphate groups was performed by acid phosphatase, 
the samples were desalted and the parental nucleosides ZDV, 3TC and AZdU (azidodeoxy‐
uridine; internal standard added to the extract after enzyme digestion) were extracted by 
means of a solid phase extraction (SPE) XAD resin column. HPLC separation was performed 
on an RP column with a mobile phase consisting of methanol and acetonitrile mixture (3:1, 
v/v) with 0.25% acetic acid. The concentrations of the analytes were determined by using 
ZDV/AZdU and 3TC/AZdU peak area ratios, and calibration curves from ZDV‐TP and 3TC‐
TP standard solution were prepared every time a series of samples was analysed [22].
The next indirect method was developed for the analysis of intracellular dideoxyadenosine 
triphosphate (ddATP). Cells were treated with 70% MetOH buffered to pH 7.4 and the sam‐
ples were incubated on ice for 15 min and stored at −20°C. Before analysis the cell extract was 
evaporated to dryness and reconstituted in Tris (1 M, pH 7.4). The samples were loaded onto 
a QMA anion exchange SPE cartridge, MP and DP were eluted by 75 mM KCl, and finally 
ddATP was eluted with 500 mM KCl. The pH of the eluate was adjusted to 6.0 and it was 
incubated with acid phosphatase for 30 min at 37°C for dephosphorylation to ddA (dide‐
oxyadenosine). The samples were desalted and purified using C18 SPE cartridges. The ddA 
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eluted by AcCN was evaporated to dryness and stored at −20°C until analysis. The overall 
recovery of QMA and C18 SPE was over 95%. The separation was performed on a Purospher‐
RP‐18e column with a mobile phase consisting of MetOH/water (25/75, v/v) containing 1% 
formic acid. The overall analysis was achieved within 1 min. The LOQ of ddA in the CEM‐T4 
cells that were analysed was 0.02 ng mL−1. This procedure could be used to perform simulta‐
neous detection of five NRTIs, such as AZT, 3TC, ddA, ddC, and d4T [33].
An indirect method for the determination of the nucleoside analogues MP, DP and TP in an 
intracellular matrix of red blood cells (RBC) and PBMCs was described by Bushman et al. 
Cell extracts were loaded onto QMA SPE cartridges and MP, DP and TP fractions were eluted 
by means of a KCl concentration gradient. The isolated fractions were then treated with acid 
phosphatase for dephosphorylation to parental nucleoside and the samples were desalted 
and concentrated with a Strata X‐SPE column, and the eluent was dried under nitrogen at 
40°C and reconstituted in water. Separation was achieved on a Synergi Polar RP column. The 
phase for tenofovir (TFV) contained 2% AcCN and 0.1% formic acid in pure water with a run 
time of 8 min, and for zidovudine (ZDV) it contained 6% 2‐propanol and 0.1% acetic acid in 
pure water with a run time of 12 min, both at an isocratic flow. The method was successfully 
applied to clinical research generating novel intracellular information for TFV, emtricitabine 
(FTC), ZDV and 3TC nucleotides [14].
Another indirect method for the determination of adenosine, guanosine and inosine nucleo‐
tides was introduced by Jimmerson et al. The analyses were performed on human PBMCs, 
red blood cells (RBCs) and dry blood spots (DBSs). Methanolic extracts of lysed cells and 
DBSs were fractionated to MP, DP and TP using an anion exchange cartridge and a potassium 
chloride salt gradient. The resulting separated fractions were dephosphorylated to the paren‐
tal nucleosides adenosine, guanosine, and inosine by alkaline phosphatase. Subsequently, the 
samples were desalted and concentrated on phenylboronic (PBA) SPE cartridges. Analytical 
separation was performed on an RP column with an aqueous mobile phase containing 4% 
AcCN and 0.1% formic acid. The detection of nucleosides was performed in positive ESI MRM 
mode [15]. This group of authors previously described a similar method for the determination 
of intracellular ribavirin (RBV) MP, DP and TP, in which the particular fractions were  isolated 
from a lysed intracellular matrix using strong anion exchange SPE, dephosphorylated to 
parent RBV, desalted and concentrated on PBA SPE cartridges and subsequently analysed. 
Chromatography was performed on a Reversed‐Phase‐Aqueous column (Develosil C30) with 
a mobile phase consisting of 2% AcCN and 0.1% formic acid in water at an isocratic flow and 
with a run time of 4 min. Each injection was followed by strong and weak needle washing. 
The method was used on human PBMCs and the RBC and DBS of patients taking RBV for the 
treatment of chronic hepatitis C virus infection [59].
Wang et al. described a method for the determination of creatine phosphate, creatine and 12 
nucleotides in rat heart tissue. The extract was separated on a polar endcapped C18 column 
that was suitable for reversed‐phase separations using highly aqueous mobile phases. The 
mobile phase consisted of 2 mM ammonium acetate in water adjusted with ammonia to pH 
10.0 and isocratic elution was applied. The detection was performed by negative electrospray 
ionization in selection reaction monitoring mode. The study was, however, focused only on 
group of nucleotides of which the concentration in the tissue is relatively high [45].
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The determination of 3′‐deoxy‐3′‐fluorothymidine (FLT) and FLT‐MP was used for the moni‐
toring of serum thymidine kinase 1 (TK 1) activity. Separation was achieved on an Aquasil 
C18 column coupled with a security guard column (Gemini C18) using 0.1% formic acid in 
water (MF A) and 0.1% formic acid in AcCN (MF B). Elution was carried out under gradient 
conditions with a total analysis time of 7 min. The applicability of the method for measuring 
serum TK 1 activity was demonstrated in hepatocellular carcinoma patient serum samples 
and age‐matched control sera [58].
Several methods for the determination of cyclic nucleotides with separation on RP‐HPLC 
columns have been developed. Oeckl et al. described a method for the analysis of cAMP and 
cGMP in plasma, CSF and the brain tissue of mice. For separation a Varian MetaSil RP column 
with a mobile phase consisting of 0.1% formic acid in water (A) and acetonitrile (B) was used. 
The analysis time per sample was 3.5 min [36]. The method was subsequently applied in mea‐
suring cAMP and cGMP concentrations in CSF in patients with Creutzfeldt‐Jakob disease, 
Parkinson’s disease and amyotrophic lateral sclerosis. It demonstrated that the CSF determi‐
nation of cAMP and cGMP may be included in the diagnosis of CJD and could be helpful in 
monitoring the progress of the disease as well as in therapy control [62]. The same separation 
conditions were used for the determination of cGMP in human plasma in a study by Zhang 
et al. [37]. In a method for the measurement of 2′,3′‐cAMP, 2′,3′‐cCMP, 2′,3′‐cGMP and 2′,3′‐
cUMP, separation on a Zorbax eclipse XDB‐C18 column connected to a security guard column 
with MetOH/water (3:97, v/v) as MF A and MetOH/water (97:3, v/v), each containing 5 mM 
ammonium acetate and 0.1% acetic acid, was achieved. The analysis was applied to the analy‐
sis of nucleotides in two different cell lines, Hek293T and HuT‐78 [30].
Another use of reversed‐phase analytical columns for the determination of nucleotides is 
 possible with the addition of an ion‐pairing reagent into the mobile phase [31, 41, 82]. This is 
described in detail in the chapter ‘Ion‐pairing chromatography’.
4.2. Ion exchange chromatography
Ion exchange chromatography (IXC) is a separation technique applied to the analysis of 
charged molecules, including, e.g. ions, polar nucleotides and amino acids, on the basis of 
their affinity to the ion exchanger. For positively charged analytes, cation exchange chroma‐
tography with negatively charged solid support is used and vice versa; negatively charged 
analytes are attracted to a positively charged solid support in anion exchange chromatogra‐
phy (AX). The elution of bounded negatively charged molecules is performed with an eluent 
containing anions in a higher concentration or by changing the pH of the column. The elu‐
tion of strongly charged nucleotides requires a high concentration of competitive ions in the 
mobile phase and, thus, hyphenation with MS detection cannot be employed.
However, an alternative elution mechanism introduced by Shi et al. based on the application 
of a pH gradient enabled the direct quantification of intracellular nucleoside triphosphates 
(NTPs) without any need for high concentrations of non‐volatile competing ions for elution. 
Extracts of human PBMCs were analysed by weak anion exchange (WAX) liquid chroma‐
tography coupled to mass spectrometry detection. An inverse ammonium acetate gradient 
(10−1 mM) enabled separation between MPs, DPs and TPs within 2 min. The method was 
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 validated and used for the determination of the NRTI dexelvucitabine triphosphate metabo‐
lite in human PBMC samples from clinical studies [85].
Veltkamp et al. developed a sensitive and specific assay for the quantification of gemcitabine 
triphosphate (dFdCTP) in human PBMCs. It is based on a WAX LC‐MS/MS approach, 
which makes the method more sensitive [17] than previously published work based on UV 
 detection [70].
Jansen et al. developed and validated a method for the quantitative analysis of cladribine 
mono‐, di‐ and triphosphates that was applied to a culture medium and MDCKII cell lysate. 
WAX LC‐MS/MS in positive ion mode was applied via a fused‐silica electrospray capillary 
instead of a stainless steel electrospray capillary to minimize the adsorption of analytes and, 
thus, reduce the variation in the analyte signals [27].
A simultaneous quantification method for 11 relevant nucleotide metabolites of thiopurine 
drugs (eleven mono‐, di‐ and triphosphates of thioguanosine, methylthioinosine, methylthio‐
guanosine and thioinosine) in RBCs was introduced by Hofmann et al. Ion exchange HPLC 
on a WAX column using a pH gradient from 6 to 10.5 and a decreasing ammonium acetate 
concentration from 10 to 1 mM was used for the separation of nucleoside mono‐, di‐ and 
triphosphates. All eleven metabolites could be determined in RBCs from patients with inflam‐
matory bowel diseases and long‐term azathioprine therapy indicating high inter‐individual 
variability of the metabolite levels. Using stable isotope‐labelled analogues of the metabolites 
enabled the reproducible and accurate determination of all the analytes [13].
Anion exchange chromatography was also used for the determination of 2′‐C‐methylguano‐
sine triphosphate concentration in mouse liver in a study by Rashidzadeh et al. The samples 
were eluted onto a Luna NH
2
 chromatographic column with 1 mM ammonium acetate in 
water/AcCN (70:30, v/v), pH 8.0 (MP A) and 20 mM ammonium acetate in water/AcCN (70:30, 
v/v), pH 10. The total run time was 10 min per sample. The assay was linear over a 50–10,000 
pmol mL−1 concentration range in liver homogenate [42].
In a paper by Derissen et al., the development of an LC‐MS/MS assay for the quantification 
of the widely used chemotherapeutic capecitabine with the active component 5‐ fluorouracile 
(FU) and its active metabolites FUTP, FdUTP and FdUMP was described. Because of the low 
concentrations of the analytes, the optimization of the sample preparation, including cell lysis 
and nucleotide extraction and subsequent chromatographic separation, was necessary. The 
samples were loaded onto a BioBasic AX WAX column coupled with a guard column; the 
mobile phase A and B composition was 10 mM ammonium acetate with pH 6.0 and 1 mM 
ammonium acetate with pH 10.5, respectively, both in AcCN/water (30:70, v/v). The pH 
 gradient was applied to achieve effective separation of the MP, DP and TP of the nucleoside. 
The total analysis time was 7 min. The method was validated for the concentration ranges 
0.488–19.9, 1.66–67.7 and 0.748–30.7 nM for FUTP, FdUTP and FdUMP, respectively. The 
assay was successfully applied to quantify 5‐FU nucleotides in PBMC samples from patients 
treated with capecitabine and patients receiving 5‐FU intravenously [18]. The method was 
also used for the quantification of the 5‐FU nucleotides in PBMCs in a study exploring the 
intracellular pharmacokinetics of the 5‐FU nucleotides during capecitabine treatment [57].
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The WAX principle can also be used for sample preparation by SPE with Wax extraction car‐
tridges followed by separation on RP or PGC columns [81, 83]. This was described previously 
in the chapter ‘Sample preparation’.
4.3. Porous graphitic carbon columns
Another way to achieve the required separation of nucleosides is the use of porous graphitic 
carbon columns (PGC) because of their unique properties as a stationary phase. Their reten‐
tion and selectivity for polar and structurally related compounds is different from conven‐
tional C18 columns. PGC is very suitable for the analysis of polar and ionic compounds, 
which are retained on the carbon surface without a need for an IP reagent, and the subsequent 
elution is not dependent on a high salt concentration. This enables the development of meth‐
ods compatible with MS detection. PCG columns have the advantage of physical and chemi‐
cal stability accompanied by toleration of a wide pH range (0–14). Retention increases with 
increasing analyte hydrophobicity [86]. However, PGC behaves as a strongly retentive alkyl‐
bonded silica gel for non‐polar analytes. Thus, the disadvantage is the difficulty of desorption 
of non‐polar compounds adsorbed on the surface and a general loss of retention on PGC 
within a run and over a period of time, which can limit their use [87].
A general LC‐MS method for the analysis of nucleosides and their mono‐, di‐ and triphos‐
phates using a PGC column was developed by Xing et al. The method was optimized using 
different organic mobile phases and modifiers. The concentration of ammonium acetate 
was proved to be a critical step for retention during gradient elution with water/acetoni‐
trile. Diethylamine (DEA) was found to improve the peak shapes of di‐ and triphosphates 
for mass spectrometric detection. Finally, the separation of 16 nucleosides and nucleotides 
was achieved during 15 min under the conditions of a gradient of ACN in water with 50 mM 
ammonium acetate and 0.1% DEA. In the study, comparison of several silica‐based columns 
for separation of polar compounds was also performed. Hypercarb column provided the best 
results for separation and quantitation of the nucleotides and their phosphates [88].
Wang et al. described an LC‐MS/MS method for the determination of AMP, ADP and ATP in 
the extract of HepG‐2 cells. Chromatographic separation was performed on a PGC analytical 
column with a basic mobile phase. Negative‐ion mode ESI‐MS with basic mobile phase con‐
dition improved the sensitivity of the MS analysis. The method was successfully applied to 
determine ATP, ADP and AMP in HepG‐2 cells treated with benzo[a]pyrene [25]. This method 
served as a model for a study focused on the quantification of gemcitabine (2′‐2′‐difluorode‐
oxycytidine, dFdC) and its metabolites 2′‐2′‐difluorodeoxyuridine (dFdU) and 2′‐2′‐difluoro‐
deoxycytidine‐5′ (dFdCTP) in pancreatic ductal adenocarcinoma tumour tissue and plasma 
from genetically engineered mouse models of pancreatic cancer. The tumour tissue was 
homogenized in ice‐cold 50% AcCN containing tetrahydrouridine. An aliquot of homogenate 
was mixed with ice‐cold 50% AcCN containing IS. After vortex mixing and centrifugation 
the supernatant was evaporated to dryness and reconstituted in water before analysis. With 
respect to plasma, it proceeded in the same way as the tumour homogenate by the addition of 
ice‐cold 85% AcCN containing IS. The analytes were separated on a PGC Hypercarb column 
fitted with a guard column with 10 mM ammonium acetate, pH 10 (MF A) and acetonitrile 
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(MF B); the total run time was 15 min. In order to minimize carry‐over between injections, the 
needle and injection path were flushed using the external wash procedure with water, 100% 
AcCN, 50% AcCN and water [46].
Jansen et al. also introduced a method for the separation of 2′‐2′‐difluorodeoxycytidine (gem‐
citabine, dFdC), 2′‐2′‐difluorodeoxyuridine (dFdU) and their mono‐, di‐ and triphosphates 
using a porous graphitic carbon Hypercarb column. The separation of all the analytes was 
achieved using an ammonium bicarbonate gradient (0–25 mM) in acetonitrile/water. The rate 
of pH and redox state of the column had to be controlled in order to maintain the separation 
conditions within multiple runs [89]. Subsequently, this method was validated for quantifica‐
tion in PBMCs and successfully applied to clinical samples [90].
Another method utilizing PGC‐HPLC column separation with MS detection was developed 
for the quantification of cytarabine triphosphate (araCTP), CTP and dCTP in a human fol‐
licular lymphoma cell line. The separation principle is based on an LC‐MS/MS ion pair using 
a PGC analytical column. The mobile phase consisted of 5 mM hexylamine with 0.4% dimeth‐
ylhexyl amine with a pH of 10 and an ACN/water mixture. The mass spectrometer operated 
in negative ESI and multiple reaction monitoring mode. The method was able to achieve a 
low limit of quantification (LLOQ) of 0.1 μg mL−1 for araCTP and of 0.01 μg mL−1 for both CTP 
and dCTP. The method was validated and used for the quantification of araCTP, CTP and 
dCTP formed after the incubation of araC and an araCMP prodrug in the human follicular 
lymphoma cell line RL [81].
The development and validation of an assay for the quantification of endogenous nucleo‐
side MP and TP by LC‐MS/MS in combination with online SPE extraction was introduced 
by Machon et al. An Oasis®WAX SPE column served for online extraction, whereas PGC 
Hypercarb® was used as an analytical separation column. The elution solvents were 0.25% 
NH
4
OH adjusted to pH 10 with acetic acid (A), water (B) and acetonitrile (C). The IP reagent 
was used for the reconstitution of the evaporated samples (5 mM hexylamine—0.5% DEA in 
water) to prevent peak tailing of nucleoside triphosphates. The total duration of a single run 
was 37 min. The method also allowed the separation and the detection of other nucleoside 
MP, DP and TP, deoxyribonucleotides and ribonucleotides. The advantage of the method was 
that it was based on online SPE, which was less time‐consuming. After validation, the method 
was applied to the evaluation of the effects of gemcitabine and hydroxyurea on nucleotide 
pools in Messa cells [29].
Kamčeva et al. also introduced a combination of ion‐pairing chromatography with PGC col‐
umn separation. The development of a sensitive LC‐MS/MS method for the separation and 
quantification of eight endogenous nucleotides (ATP, CTP, GTP, UTP, dATP, dCTP, dGTP and 
dTTP) and 2’, 2’‐difluoro‐2’‐deoxycytidine triphosphate (dFdCTP) in PBMCs was described. 
The analytes were extracted by simple protein precipitation and chromatographic separation 
was performed on a Hypercarb column with delivery of a mobile phase containing 5 mM HA, 
0.5% DEA, acetonitrile and water in gradient elution adjustment. The total analysis time was 
68 min. The method was applied to monitor dFdCTP and changes in endogenous nucleotides 
in patients who were receiving gemcitabine infusions [60].
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Nowadays, methods using PGC column separation represent a good alternative for nucleo‐
tide analysis compatible with MS detection in a robust and reproducible manner without the 
need for an ion‐pairing agent or a high salt concentration. The optimization of mobile phase 
composition and an appropriate elution program facilitating consistent analyte retention 
remove the need for column regeneration, minimize run times and thus allow PGC columns 
to be used to their full potential [88].
4.4. Ion‐pairing chromatography
Separation by ion‐pairing (IP) chromatography (IPC) is based on the interaction between the 
negatively charged nucleotides and the positively charged IP reagent. The stationary phase is 
usually the commonly used non‐polar C18 or C8 phase. The mobile phase contains cationic 
reagents such as alkylamines. The previously used tetrabutylammonium salts were effective 
for the separation of nucleotides by HPLC in combination with UV detection. However, non‐
volatile tetrabutylammonium salts were incompatible with electrospray‐mass spectrometry 
detection. Thus, a more volatile salt is one of the possible ways to overcome this problem. 
Triethylamines, tributylamines, dibutylammonium salts, dimethyhexylamine or hexylamine 
are commonly used. The properties of the mobile phase are optimized for the efficient desorp‐
tion of analytes using organic modifiers such as methanol or acetonitrile and also by the pH 
gradient. The concentration of the ion‐pairing reagent plays a crucial role in LC separation 
coupled with MS detection. The amount has to be optimized for successful separation and 
for minimizing the mass spectrometry ion source contamination. Two of the solutions for 
reducing the electrospray ion source pollution are to minimize the flow rate of the mobile 
phase into the MS system or to use trialkylamine with a longer chain, promoting interactions 
between the IP reagent and a hydrophobic stationary phase, resulting in a reduction in the 
amount of the IP agent required. Another way is column miniaturization, which provides 
 better chromatographic resolution and sensitivity of the LC‐MS system [9].
The first study introducing IP capillary HPLC‐MS described the separation of cyclic nucle‐
otides on a C18 reversed‐phase column using tetrabutylammonium (TBA) bromide as the 
IP agent. Different mobile phase compositions were evaluated in the concentration range of 
50–500 μM of TBA salt with a combination of low flow rates (5–10 μL min−1) in combination 
with negative electrospray ionization. Despite the relative non‐volatility of TBA salt, the sys‐
tem was able to operate for several days without a reduced signal caused by source pollution 
being observed. Optimal conditions offered linear detection response in the femtomole to 
picomole range [91].
Claire et al. introduced the IP‐HPLC‐MS method for the determination of intracellular 
emtricitabine triphosphate (FTC‐TP) levels in human PBMCs that was also adaptable to all 
purine‐ and pyrimidine‐based nucleotides. All the nucleotides were extracted by means of 
aqueous methanol, isolated by IP‐SPE and then directly analysed by LC‐MS/MS. The mobile 
phase contained 10 mM ammonium phosphate, pH 6.4, with 2 mM tetrabutylammonium 
hydroxide and 15% acetonitrile. The method was linear in the range from 0.08 to 80 picomoles 
 on‐ column. The low amount of TBA, thin column with a 1.0‐mm internal diameter, slow flow 
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rate of 50 μL min−1 and continuous flow of 20% methanol through the MS ion source enabled 
effective separation and detection stability [92]. Hawkins et al. applied the method for the 
simultaneous determination of the intracellular concentrations and pharmacokinetics of teno‐
fovir diphosphate, carbovir triphosphate and lamivudine triphosphate in samples of patients 
on a triple‐nucleoside regimen [93].
The IP‐RP‐LC‐MS/MS method was developed for the quantitative detection of adefovir and 
its phosphorylated metabolites in cellular samples by Vela et al. Hep G2 cells were incubated 
with 10 μM adefovir for 24 h and then extracted using 70% methanol. Chromatographic sepa‐
ration was performed on microbore reversed‐phase columns and a mobile phase containing 
TBA and ammonium phosphate was delivered to the MS system with a low flow of aceto‐
nitrile gradient. Further optimization of the method lowered the concentration of TBA and 
phosphate, reduced the pH and applied a linear gradient of acetonitrile. Thus, the method 
was found to have sufficient sensitivity, accuracy and precision to be broadly applicable. But 
despite all the improvements and optimization of the method, using TBA in the injection 
solvent caused significant ion suppression and phosphate clusters, and their ammoniated 
adducts also created a number of high‐intensity interfering peaks [28]. Finally, TBA in combi‐
nation with phosphates causes mass spectrometer ion source pollution, ion suppression and 
background interference that impose some limitations on the determination of nucleotides 
using IP‐LC‐MS/MS. Regardless of this, methods using TBA with a limited ion‐pair concen‐
tration and maintaining low flow rates have been successfully used in many applications.
Trialkylamines are more suitable for MS detection because of their higher volatility than 
 tetraalkylammonium salts. Apffel et al. developed a method for the analysis of oligonucle‐
otides by RP‐HPLC‐ESI‐MS. The mobile phase contained a novel additive, hexafluoropro‐
panol (HFIP), adjusted to pH 7.0 with triethylamine (TEA). This combination resulted in 
good HPLC separation and efficient negative electrospray ionization. Application was dem‐
onstrated for synthetic homopolymers of thymidine, mapping plasmid sequence fragments 
and phosphorothioate ester antisense oligonucleotides with sensitivity below the 10 pmol 
level [94].
The IP LC‐MS/MS method for the simultaneous determination of intracellular nucleoside 
 triphosphates and other polar metabolites using a TEA‐HFIP IP mobile phase was described 
by Wu et al. Compared to the less volatile ion‐pair reagent triethylammonium acetate (100 mM, 
pH 7.0), the combination of 100 mM HFIP and 8.6 mM TEA increased the MS signal intensity 
about 50‐fold, while retaining comparable chromatographic resolution. A  gradient elution 
program with a total analysis time of 10 min was developed. The method was  optimized and 
validated for the simultaneous and unambiguous determination of eight nucleoside triphos‐
phates (including ATP, CTP, GTP, UTP, dATP, dCTP, dGTP and dTTP) and applied to sam‐
ples of human lung cancer cell lines. The method can be used for the quantitative profiling of 
74 polar metabolites with minor modifications and a prolonged mobile phase gradient [32].
Another widely utilized IP agent is N,N‐ or 1,5‐dimethylhexylamine (DMHA). DMHA served 
as an ion‐pairing agent for the identification and quantification of bisphosphonates,  synthetic 
analogues of pyrophosphate that are used in the treatment of metabolic bone  diseases. 
They can be metabolized intracellularly into non‐hydrolyzable nucleotide analogues. The 
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 separation was performed on a C18 reversed‐phase LC column with MS detection in negative 
ESI mode [95, 96].
Tuytten et al. demonstrated the influence of different N,N‐DMHA concentrations on the chro‐
matographic and mass spectrometric performance. They developed the IP‐LC‐MS method 
using a short capillary column for the separation of 12 nucleotides eluted by a binary gradient 
of methanol/water/DMHA. Chromatographic performance and MS detection were improved 
by the addition of ammonium dihydrogen phosphate [97].
Another routine method for the simultaneous determination of the intracellular nucleotides 
of NRTI stavudine (d4T), as well as the natural corresponding triphosphate in human PBMCs, 
was developed and validated by Pruvost et al. Separation was performed on a reversed‐phase 
microbore column with an IP reagent coupled to tandem mass spectrometry with negative 
electrospray ionization and multiple reaction monitoring detection mode. The LOQ for d4T‐
TP was 138 fmol per 7 mL blood. The method was applied to samples from patients treated 
with stavudine and could be used on more than 35 samples per day. However, the robust‐
ness was poor as a result of column instability because of the application of a high pH [23]. 
The method was subsequently improved; several HPLC columns were compared in order to 
enhance the stability of the peak shape over time. The SMT C18 column was replaced with a 
Supelcogel ODP‐50, which is more stable under high‐pH conditions. This method was suc‐
cessfully applied to clinical samples of HIV‐positive patients receiving antiretroviral therapy 
containing d4T, ddI (didanosine) and/or 3TC (lamivudine) for the simultaneous determina‐
tion of its triphosphate metabolites [98]. The problem with interference that occurred in the 
method was resolved by changing the polarity of the ion source during analysis and look‐
ing for another fragmentation pattern of the interfering molecules, resulting in the formation 
of different product ions without loss of sensitivity. Validation of the improved method for 
the simultaneous determination of carbovir triphosphate (CBV‐TP), lamivudine triphosphate 
(3TC‐TP) and tenofovir diphosphate (TFV‐DP) was performed. The composition of the mobile 
phase was not changed (1,5‐DMHA, pH = 10.5). The total run time was 12 min, as opposed to 
26 min for NRTI analysis. The positive ESI offered better specificity and slightly better sensi‐
tivity than the negative ESI mode for these compounds and resulted in enhanced specificity 
and more robust assay methods. This assay was applied to PBMC samples from HIV‐infected 
patients with NRTI therapy [16].
The separation of several nucleotides and related phosphate‐containing metabolites using 
IP‐LC with DMHA was introduced in the study of Cordell et al. A reversed‐phase chromato‐
graphic column was loaded with a mobile phase consisting of water and MetOH in various 
ratio (95:5 for MF A and 20:80 for MF B), with the addition of DMHA in the concentration 
range 0.5–20 mM and the pH being adjusted by means of acetic acid. The optimized method 
enabled the simultaneous detection of 24 nucleotides and related phosphorylated compounds 
in negative ESI mode. The method that had been developed was then applied to profile 
endogenous levels of intracellular nucleotides in cultured CHO cells [31].
Chen et al. also introduced the IP‐LC‐MS/MS method for the analysis of intracellular nucleo‐
side triphosphate levels using DMHA as the IP reagent in MF. The analysis was performed on 
a Supelcogel ODP‐50 column coupled to an Xterra MS C18 guard column with a mobile phase 
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comprising 5 mM DMHA in water buffered to pH 7 by formic acid as MF A and 5 mM DMHA 
in AcCN (50:50, v/v) as MF B. The method was applied to five different human  leukemia cell 
lines and bone marrow samples of leukemia patients. It enabled the determination of CTP, 
dCTP, UTP, GTP, dTTP, dGTP/ATP, dATP and 2‐chloroadenosine (IS) within a run time of 
40 min [26].
An analytical method for 2′‐fluoro‐5‐methyl‐beta‐L‐arabinofuranosyluracil (L‐FMAU) tri‐
phosphate, a novel L‐nucleoside analogue of thymidine known as an inhibitor of the hepatitis 
B virus, was introduced for the determination of its levels in PBMCs. Ion‐pairing chromatog‐
raphy coupled with negative ion electrospray ionization tandem mass spectrometry showed 
accurate and repeatable detection, the intra‐ and inter‐day precision was lower than 11.2%, 
and the accuracy was between 97.1 and 106.9%. The method was applied to HBV‐infected 
patients undergoing L‐FMAU treatment [99].
Becher et al. developed a method for the direct determination of intracellular levels of zidovu‐
dine (AZT) triphosphate in human PBMCs. Mobile phase A consisted of 10 mM DMHA and 
3 mM ammonium formate, the pH being approximately 11.5, and mobile phase B contained 
20 mM DMHA and 6 mM ammonium formate/acetonitrile (1:1). Separation proceeded on an 
SMT C18 column and the total analysis time was 26 min. The method was applied to PBMCs 
from HIV‐infected AZT‐treated or AZT‐free patients [21]. Compain et al. extended the method 
to ATP monophosphate and the analytical run time was reduced to less than 10 min. The 
low limits of quantification were at 150 and 300 fmol per sample for AZT‐TP and AZT‐MP, 
respectively. The improved method offered the possibility of simultaneous determination of 
other nucleotide phosphates such as d4T‐TP or dTTP [100]. Durand‐Gasselin et al. [20] evalu‐
ated potential NRTI toxicity in newborns from a human immunodeficiency virus‐infected 
mother with antiretroviral prophylaxis by the determination of zidovudine (AZT) and lami‐
vudine (3TC) metabolites in PBMCs together with the level of the parent drug in plasma. Till 
then the pharmacological monitoring of these drugs in newborns had been  limited to plasma 
and cord blood. The LC‐MS/MS method for PBMC samples was adapted from previously 
reported assays [21, 100], with minor modifications concerning AZT‐MP monitoring [20]. The 
method was improved by Kinai et al. The extraction of PBMC using a double tube filled with 
silicon oil completely removed residual plasma phosphates and sodium salts. Together with 
mobile phase alkalization, using of alkaline‐stable HPLC column and tetrabutylammonium 
 hydroxide as the IP reagent resulted in higher sensitivity in comparison with the previous 
method [19].
Hernandez‐Santiago et al. developed a method with gradient elution of decreasing DMHA 
concentration during analysis. Their MS system operated in negative electrospray mode. The 
assay was applied predominantly for the determination of β‐D‐N4‐Hydroxycytidine (NHC) 
triphosphate, a metabolite of a nucleoside analogue with selective anti‐hepatitis C virus 
 activity. In pre‐clinical studies, the metabolism of the drug was investigated in various liver 
cells and primary human hepatocytes. Although a decreasing concentration of IP reagent 
was applied, the MS ion source and the whole LC column had to be regularly cleaned with a 
water‐methanol mixture (50:50, v/v) at the end of each day [101].
Luo et al. focused on the identification and quantification of intracellular metabolites involved 
in central carbon metabolism, including glycolysis, the pentose phosphate pathway and the 
Mass Spectrometry154
tricarboxylic acid cycle. Separation was performed on an RP C18 column with a mobile phase 
consisting of 10 mM tributylamine aqueous solution with the pH adjusted to 4.95 with 15 mM 
acetic acid as eluent A and methanol as eluent B. The total analysis time was 80 min, and 
before each run, the column was equilibrated for 10 min. The method enabled the determina‐
tion of 29 negatively charged compounds, including several nucleotides [47].
Hexylamine (HA) as an IP agent was used in the study of Fromentin et al., which was aimed 
at the determination of several clinically relevant nucleotide analogues and endogenous 
nucleotides. Separation was optimized for a Hypersil Gold C18 column, which offered the 
best results compared to other columns that were tested. The mobile phases A and B used in 
the method for partial validation consisted of 2 mM ammonium phosphate buffer containing 
3 mM HA and acetonitrile, respectively. A gradient elution program was applied. The study 
was applied to human PBMC and macrophages, but it could also be applied for the quantifi‐
cation of other NRTIs with slight modifications [82].
A combination of IPC separation on PGC columns was also introduced in some studies. For a 
detailed description see the chapter ‘Porous graphitic carbon columns’ [60, 81].
Thanks to the reduced amount of IP reagent and salts entering the ion source, several robust 
methods for nucleotide determination with acceptable ion suppression have been developed 
and applied. However, pollution of the ion source remains the major problem.
4.5. Hydrophilic interaction liquid chromatography
Hydrophilic interaction liquid chromatography (HILIC) is an emerging separation mode of 
LC. In this variant of normal‐phase LC, polar columns with a hydrophilic stationary phase 
are used in combination with a mobile phase consisting of reversed‐phase‐type eluents rich 
in organic solvents. Stationary phases used in HILIC configuration can contain a simple non‐
polar silica phase or can be modified by amino, anionic, amide, cationic or zwitterionic bonded 
phases. A typical mobile phase of HILIC mode consists especially of acetonitrile with a small 
amount of water or also alcohol in a higher concentration than the aprotic solvent to achieve 
the same retention behaviour. Polar analytes are eluted from the column by increasing the 
water content of the mobile phase. In HILIC, the analyte is distributed between a water‐rich 
layer on the surface of the polar stationary phase and the organic mobile phase layer, creat‐
ing a liquid‐liquid extraction system. The mechanism of HILIC also includes hydrogen donor 
interactions between neutral polar species as well as weak electrostatic mechanisms under 
the high organic solvent conditions used for retention. Hence, this separation mode partly 
overlaps with ion chromatography and reversed‐phase liquid chromatography. The reten‐
tion behaviour of analytes, peak shape and chromatographic tailing are also controlled by 
the pH of the mobile phase and the ion strength formed by ionic additives, such as ammo‐
nium acetate and ammonium formate. The applied mobile phases are highly volatile, and 
thus the hyphenation with MS is friendly and favourable. HILIC mode showed very high 
efficiency for the retention of polar analytes that offered a different selectivity in comparison 
with the traditionally used RP‐HPLC. High throughput of HILIC‐MS/MS analysis at a high 
flow rate was allowed as a result of the very low column backpressure contributed by the 
high‐organic mobile phase. Direct injection of the organic solvent extracts through LLE, SPE 
and PP onto the HILIC column is possible, in contrast to regular RP‐HPLC. HILIC‐MS/MS 
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has been  demonstrated to be a very important supplement to the RP‐HPLC‐MS/MS for the 
analysis of polar compounds [102, 103].
The HILIC‐MS method for the simultaneous determination of 141 endogenous metabolites, 
including several nucleotides, was introduced by Bajad et al. Separation was performed on 
an aminopropyl column with an alkaline mobile phase consisting of ammonium acetate and 
ammonium hydroxide as solvent A with a pH of 9.45 and acetonitrile as solvent B. A  gradient 
elution program was used and the total analysis time was 40 min with five time segments 
in positive mode and 50 min with four time segments in negative mode. The method was 
applied to extracts of E. coli grown in [12C] vs. [13C] glucose and revealed appropriate 12C‐ 
and 13C‐peaks of 79 different metabolites [43].
The complex metabolomics method using HILIC separation mode was developed by 
Karlíková et al. Separation was performed on the Luna NH
2
 aminopropyl column with MP 
A consisted of 20 mM ammonium acetate at pH 9.75 and the mobile phase B consisted of 
AcCN. Gradient program was used for elution of targeted analytes. The total analysis time 
was 17 min. The method allowed analysis of 354 compounds as a result of continuous switch‐
ing of positive and negative mode and detection of analytes using scheduled MRM mode. 
The method was applied on the metabolite profiling of the plasma and leukocytes of chronic 
myeloid leukemia patients [104].
Similar separation conditions were used for the determination of 2‐methylcytidine triphos‐
phate in a study by Pucci et al. Separation was performed on an aminopropyl column with 
ammonium acetate, pH 9.45 and acetonitrile. The chromatographic gradient was modified 
and reduced to 30 min, and the detection of the ions was performed in the negative ESI MRM 
mode. The calibration curve was linear over the 0.05–50 μM concentration range. The method 
has been successfully applied for pharmacokinetic studies of 2′‐C‐methyl‐cytidine‐triphos‐
phate in rat liver tissue samples [39].
Teleki et al. also introduced alkaline conditions in HILIC mode for the quantitative profiling 
of more than 50 hydrophilic intracellular key metabolites. Separation was performed on a 
ZIC‐pHILIC column. Optimization was focused on the pH of the mobile phase, buffer con‐
centration, flow rate, column temperature and the gradient slope of the polar eluent. In opti‐
mized chromatographic conditions the mobile phase consisted of 10% aqueous buffer solution 
(10 mM ammonium acetate) and 90% acetonitrile for eluent A and 90% aqueous buffer with 
10% acetonitrile for eluent B, both adjusted to a pH of 5.6 with acetic acid or a pH of 9.2 with 
ammonium hydroxide. The column was kept at 40°C, with a flow rate of 0.2 mL min−1. Under 
alkaline conditions, 98% of the metabolites showed an absolute time shift of less than 0.04 min, 
in contrast to 80% under acidic conditions. Significant differences were also observed for the 
diphosphate and triphosphate metabolites and NADP, as well as for several amino acids with 
respect to the detection limits under alkaline conditions, which were approximately 20–50 
times lower. Moreover, 70% of the metabolites presented more than 1.5‐fold higher signal 
intensities under alkaline mobile phase conditions. The quality of the method was demon‐
strated by absolute quantification of selected metabolites in intracellular extracts of E. coli 
biomasses using standard‐based external calibration, isotope dilution and standard addition 
as calibration strategies [40].
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The HILIC‐MS/MS method for the quantification of AMP, GMP, UMP, CMP and IMP in infant 
formula was developed by Inoue et al. The mobile phase used for the separation consisted of 
30 mM ammonium formate in water with a pH of 2.5 and methanol. Data acquisition was 
achieved by positive ESI MRM; the LOD and LOQ were 5–10 and 10–30 μg mL−1 for standard 
solution, respectively [79].
The HILIC‐MS/MS method was developed for simultaneous quantitative analysis of cAMP 
and ATP for measuring the effect of (partial) agonists on cAMP accumulation in vitro. The sep‐
aration of the analytes proceeded on a ZIC®‐pHILIC column with mobile phase A consisting 
of 10 mM ammonium bicarbonate buffer adjusted to a pH of 9.4 with ammonium hydroxide 
in 20% AcCN in water and mobile phase B consisting of 100% AcCN. The total run time using 
pre‐sampling was less than 6 min. The method was applied to Chinese hamster ovarian cells 
cloned and expressing the human dopamine D2L receptor [34].
Pesek et al. developed a method with the use of a silica hydride‐based stationary phase for the 
aqueous normal‐phase (ANP) retention of nucleotides. RP columns with a hydride surface 
underneath, as well as those with an unmodified or a minimally modified hydride mate‐
rial, were tested. The ANP retention of the hydrophilic nucleotides was dependent on mobile 
phases with a high organic content in combination with an additive to control ionic strength 
and pH. Both isocratic and gradient elution programs were used for separation optimization, 
and repeatability in both modes was excellent [105].
A combination of HILIC chromatography and an IP reagent was introduced by Zhang et al. This 
novel method enabled sensitive and short run‐time analysis for adenine nucleotides. The novel 
aspect of this method is based on the application of DEA‐HFIP in the mobile phase in combi‐
nation with bare silica or NH
2
 HILIC columns. This enabled successful separation of isobaric 
isomers (ATP vs. dGTP, etc.), among others. The highest sensitivity and chromatographic sepa‐
ration capacity was achieved using 100 mM HFIP and 0.5% DEA in MF at a pH of 8.9. The cali‐
bration curves showed excellent linear response over the concentration range 10–1000 ng mL−1 
for AMP and ADP and 2–200 ng mL−1 for ATP; the low levels of 10 and 2 ng mL−1 represent the 
LLOQ for individual analytes [12].
Mateos‐Vivas et al. also described the HILIC‐MS method for the separation of nucleosides and 
nucleotide mono‐, di‐ and triphosphates in the presence of hydrophilic ion‐pairing reagents. 
During optimization three analytical columns were tested with mobile phases containing a 
mixture of organic solvent (acetonitrile) and aqueous media at different pH values with differ‐
ent concentrations of salts. HILIC XBridge‐Amide was found to be the most suitable column 
for the separation of 20 nucleosides and nucleotides. The optimized mobile phase consisted 
of ACN/UHQ water mixtures with 50 mM diethylamine and 100 mM hexafluoro‐2‐propanol. 
The total analysis time was 8 min [61].
HILIC mode represents a powerful approach offering highly selective and sensitive separa‐
tion of a wide range of analytes in complex studies enabling the simultaneous analysis of a 
large number of compounds in a single run. Using volatile additives in mobile phases enables 
smooth hyphenation with mass spectrometry detection and this approach is becoming widely 
used for various analyses today.
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5. Matrix‐assisted laser desorption/ionization‐time of flight 
(MALDI‐TOF)
MALDI is a soft ionization technique used in mass spectrometry commonly applied for the 
analysis of large molecules (DNA, proteins, peptides, etc.). Analogously to ESI, it offers a 
soft ionisation to obtain ions in the gas phase. Briefly, the sample is applied to a metal plate 
together with a suitable matrix such as 3,5‐dimethoxy‐4‐hydroxycinnamic acid (sinapinic 
acid), α‐cyano‐4‐hydroxycinnamic acid (α‐CHCA, alpha‐cyano or alpha‐matrix) or 2,5‐dihy‐
droxybenzoic acid (DHB). The sample is consequently irradiated by means of a pulsed laser, 
resulting in ablation and desorption of the sample and matrix material. Finally, the analytes 
are ionized by (de)protonation by laser ionization energy transferred through the matrix mol‐
ecules and can then be accelerated into the mass spectrometer. The advantage of the method 
is its higher tolerance to salts and other contaminants from samples in comparison with other 
MS methods. MALDI‐TOF is a sensitive technique that able to detect analytes in very low 
concentrations, which also result in a small sample amount being required for the analysis 
and the reduction of the sample preparation time.
Thanks to all of these facts van Kampen et al. developed a MALDI‐TOF method for the deter‐
mination of nucleotide analogue zidovudine (AZT) triphosphate, used as an NRTI for the treat‐
ment of HIV infection, and other (deoxy) nucleotide triphosphates. Four different matrices were 
compared in order to ascertain the sensitivity and reproducibility of the method. Anthranilic 
acid in combination with nicotinic acid was selected as the most suitable matrix. AZT‐TP, ATP 
and GTP were analysed with LOD of 0.5 fmol per sample. The method was applied for the 
determination of intracellular levels of AZT‐TP and (deoxy) nucleotides in PBMCs [84].
The determination of some endogenous nucleotides was included in a metabolomic study 
by Edwards and Kennedy. MALDI‐TOF was used for the analysis of anionic metabolites, 
with 9‐aminoacridin as the matrix. The detection limits for the standards were from the nM 
to μM concentration range. The method enabled detection of overall 105 different metabolites 
in analysis of Langerhans islets extract, direct analysis of single Langerhans islet and E. coli 
extract. It was able to detect different metabolic states depending on environmental condi‐
tions such as glucose concentration and the sample type [44].
A shotgun metabolomics approach using MALDI‐TOF/TOF mass spectrometry was devel‐
oped for the rapid analysis of negatively charged water‐soluble cellular metabolites by Sun et 
al. Neutral organic extraction solvents were used to inactivate endogenous enzyme activities. 
As a result of conjunction with a matrix, that had minimal background noise, identification of 
285 peaks corresponding to negatively charged metabolites was possible. The identification 
of the metabolite peaks was based on mass accuracy and confirmation was performed using 
tandem mass spectrometry for 90 of the identified metabolite peaks. Assignments of ions 
from isomeric metabolites and their relative abundance quantitation were achieved through 
fragmentation ions originating in tandem mass spectrometry (e.g. discrimination of ATP from 
dGTP). The method is highly sensitive and facilitates the detection of extremely low‐abun‐
dance metabolites, including signalling molecules such as IP3, cAMP and cGMP. The method 
was applied to the metabolite profiling of mouse heart extracts [106].
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MALDI‐TOF is generally less popular for the identification of compounds with low molecular 
weight because of the presence of a variety of abundant matrix‐related ions in the low‐mass 
range of MS spectra and also the non‐homogenous co‐crystallization of analytes with tra‐
ditional organic matrices such as 2,5‐dihydroxybenzoic and sinapic acid. To overcome the 
problem, surface‐assisted laser desorption/ionization (SALDI) was developed to eliminate 
matrix ion interferences and improve sample homogeneity. Recently, nanoparticles have 
been investigated as an effective SALDI matrix. Huang and Chang introduced an analysis for 
the determination of ATP and glutathione using aptamer‐modified gold nanoparticles (Apt‐
AuNPs) as selective probes and gold nanoparticles (AuNPs) as the SALDI matrices with mass 
spectrometry detection. In comparison with conventional organic matrices, AuNPs as laser 
desorption/ionization (LDI) matrices provide a number of advantages, such as ease of prepa‐
ration, selectivity, sensitivity and repeatability. In combination with Apt‐AuNPs as a selective 
probe for ATP with less efficient LDI compared to AuNPs, the MS approach provided a very 
good sensitivity for ATP of 0.48 μM. The method was successfully applied to the analysis of 
ATP and GSH in human cell lysates. This approach demonstrates the practical monitoring of 
the bioactivity of cells through ATP and GSH levels [35].
Negative MALDI‐TOF‐MS appears to be a promising tool for nucleotide analysis providing 
complementary information to the armamentarium of metabolomic techniques. This tech‐
nique can provide high levels of throughput because of the simple sample preparation, with‐
out the need for chromatographic separation and short analysis time, but its usability for 
low‐mass compounds is still limited.
6. Summary
Nowadays, mass spectrometry is very important and widely applied tool in nucleotides 
analysis. As a result of technological advances in sample purification methods and mass 
spectrometry detection, the developed methods allow sensitive and selective measurement 
of polar compounds occurring in low levels in various biological matrices. This enables more 
potential uses in clinical field. Direct methods require no special sample pre‐treatment before 
analysis in contrast to indirect methods, where fractionation, dephosphorylation and puri‐
fication are needed. Previously time‐consuming chromatographic separation based on the 
number of phosphate groups was improved as a result of wide spectrum of separation pos‐
sibilities and settings. The use of IP agent in optimal amount made the methods relatively MS 
friendly. Alternative approach is the ion exchange chromatography with pH gradient used 
for elution. High selectivity in separation of closely related nucleotides can be achieved by 
using porous graphitic carbon columns. HILIC represents a promising approach for analysis 
of wide spectra of analytes including polar compounds such as nucleotides. High separation 
efficiency is also achieved with the use of CE with MS detection. Analysis of nucleotides is 
also described by the means of MALDI‐TOF, but poor reproducibility and lack of applica‐
tions make a limitation for this approach. Selected methods for determination of endogenous 
nucleotides and nucleotide analogues by mass spectrometry are summarized in Tables 1 and 2, 
respectively.
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Analysed 
nucleotides
Matrix/application Technique Nucleotides 
extraction
Separation MS polarity References
cGMP (cAMP, 
cIMP, AMP, 
GMP, IMP)
Human plasma LC‐MS/MS PP (AcCN) Metasil AQ 
C18, (RP)
MRM − [37]
cAMP, cCMP, 
cGMP, cUMP
Hek293T cells LC‐MS/MS PP 
(AcCN:MetOH:H
2
O, 
2:2:1, v/v)
Zorbax 
eclipse XDB‐
C18 (RP)
SRM + [30]
UXP, CMP, 
AXP, GXP, TTP, 
dATP
Mice islet of 
Langerhans; E. coli
MALDI‐TOF PP (MetOH) ‐ MS − [44]
AXP HepG‐2 cells LC‐MS/MS PP (PCA) Hypercarb 
(PGC)
MS − [25]
AXP, CXP, 
GXP, IXP, UXP, 
dAXP, dCXP, 
dGXP, dTXP, 
dUXP, cAMP
E. coli LC‐MS/MS PP (80% MetOH) Luna NH
2
 
(HILIC)
SRM ± [43]
CTP, dCTP, 
UTP, GTP, 
dTTP, dGTP/
ATP, dATP
human leukemia 
cells lines (K562, 
NB4, ML‐1, 
MV4‐11, THP‐1)
LC‐MS/MS PP (60% MetOH) Supelcogel 
ODP‐50 (IPC)
MRM − [26]
TXP, cAMP, 
cGMP, AXP, 
GXP, CXP
E. coli CE‐MS 
(LC‐MS/MS)
PP + LLE (MetOH + 
chloroform + H
2
O)
Fused‐silica 
50 μm × 100 
cm (Asahipak 
ODP‐50 2D)
MS − 
(MRM −)
[55]
AXP, CDP, 
CTP, GDP, 
GTP, UDP, UTP
Rat kidney tissue LC/LC‐MS PP (PCA) + online 
desalting
Zorbax C18 
+ Synergy 
Hydro C18, 
(IPC)
MS + [41]
AXP, GXP, 
CXP, UXP, 
cAMP
E. coli LC‐MS/MS PP (liquid N
2
) ZIC‐pHILIC 
(HILIC)
MRM − [40]
ATP MDA‐MB‐231 
cells
SALDI‐MS Sonication, filtration ‐ MS − [35]
CXP, UXP, 
AXP, GXP, 
cAMP, cGMP
Chinese hamster 
ovary cells (CHO)
LC‐MS/MS PP (MetOH) + LLE 
(hexane)
Symmetry 
(IPC)
MRM − [31]
AMP/dGMP, 
ADP/dGDP, 
ATP/dGTP
Human blood and 
plasma
LC‐MS/MS PP (MetOH) Luna NH
2
 
(IP‐HILIC)
MRM − [12]
AXP, cGMP E. coli LC‐MS/MS PP (60% MetOH) Synergi 
Hydro‐C18 
(IPC)
MRM − [47]
AXP, CTP, 
GXP, UTP, 
dATP, dCTP, 
dGXP, dTXP 
(CDP, dAMP, 
dCDP, dUMP, 
UDP)
H23 cells LC‐MS/MS PP (60% MetOH) + 
ultrafiltration
Atlantis T3 
(IPC)
MRM − [32]
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Analysed 
nucleotides
Matrix/application Technique Nucleotides 
extraction
Separation MS polarity References
AMP, ATP, 
dAMP, dATP, 
UMP, UTP, 
TMP, TTP, 
CMP, CTP, 
dCMP, dCTP, 
GMP, GTP, 
dGMP, dGTP
Messa cells LC‐MS/MS PP (70% MetOH) + 
online SPE (WAX)
Hypercarb 
(PGC)
MRM + [29]
GTP, ATP, UTP, 
CTP, GDP, 
ADP, UDP, 
CDP, GMP, 
AMP, UMP, 
CMP
Rat heart tissue LC‐MS/MS PP (50% MetOH) Hypersil 
Gold AQ C18
MRM − [45]
cAMP, ATP CHO‐K1 cells LC‐MS/MS Lysis buffer (63% 
AcCN, 10 mM 
NH
4
HCO3)
ZIC‐pHILIC 
(HILIC)
MRM − [34]
cAMP, cGMP Mice brain tissue, 
plasma, CSF
LC‐MS/MS PP (PCA) Varian 
Metasil AQ 
C18 (RP)
MRM + [36]
Adenosine, 
guanosine, 
inosine (AMP, 
ATP, GMP, 
GTP, IMP, ITP)
PBMC, RBC, DBS LC‐MS/MS 
Indirect
PP (70% 
MetOH) + SPE + 
dephosphorylation 
+ SPE
Develosil 
C30, RP 
aqueous
MRM + [15]
Table 1. Selected methods for determination of endogenous nucleotides using mass spectrometry detection.
Analysed 
nucleotides
Matrix/application Technique Nucleotides extraction Separation MS 
polarity
References
AZT, AZT‐XP, 
5‐methyl‐UTP, 
AZdU
PBMC/plasma LC‐MS/MS PP (EtOH) InnertSustain/
InnertSil ODS‐30 
(IPC)
MRM + [19]
AZT, AZT‐MP, 
AZT‐TP, 3TC, 
3TC‐TP, dT‐TP
PBMC/plasma LC‐MS/MS PP (Tris‐HCl/MetOH) SMT C18 (IPC) MRM ± [20]
Clofarabine‐TP PBMC LC‐MS/MS PP (AcCN) CAPCELL PAK 
CN
MRM − [24]
d4T, d4T‐XP, 
dT‐TP
PBMC LC‐MS/MS PP (Tris‐HCl/MetOH) SMT C18 (IPC) MRM − [23]
AZT‐TP PBMC LC‐MS/MS PP (TrisHCl/MetOH) 
+ immunoaffinity 
extraction
Supelcogel 
ODP‐50 (IPC)
MRM − [21]
FLT, FLT‐MP Human serum LC‐MS/MS PP (MetOH) Aquasil C18 (RP) MRM + [58]
dFdC, dFdU, 
dFdC‐TP
Mice pancreatic 
tumour tissue
LC‐MS/MS PP (aqueous AcCN) Hypercarb (PGC) MRM ± [46]
MeGTP Mouse liver 
tissue
LC‐MS/MS PP (TCA) + SPE‐WAX Luna NH
2
 (IXC) MRM + [42]
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7. Nucleotide profile of cell lines by HILIC chromatography
7.1. Introduction
We adopted and optimized the metabolomics method to cover intermediates in the  majority 
of the metabolic pathways in the cellular metabolome, as well as common metabolites pres‐
ent in urine, plasma and other biofluids, originally published by Bajad in 2006 [43]. It is 
based on HILIC separation mode, where polar negatively charged metabolites are sepa‐
rated on an aminopropyl column under strongly alkaline conditions (pH > 9). The gradient 
of the mobile phase, pH and particle size selection (3 μm) in the column was optimized. The 
list of metabolites was significantly extended by measurement in scheduled MRM mode 
and applying polarity switching. Under the final conditions, the method allows the separa‐
tion of 350 metabolites during 17 min of analysis. The method is routinely used in our labo‐
ratory [104, 107] and it was applied to the sensitive measurement of selected endogenous 
Analysed 
nucleotides
Matrix/application Technique Nucleotides extraction Separation MS 
polarity
References
MeCTP Rat liver tissue LC‐MS/MS PP (70% MetOH)+SPE Luna NH
2
 (HILIC) MRM − [39]
2CdA‐XP MDCKII cells LC‐MS/MS PP (70% MetOH) Biobasic AX (IXC) MRM + [27]
TFV‐DP, 3TC‐
TP, CBV‐TP
Human PBMC LC‐MS/MS PP (Tris‐HCl/MetOH) Supelcogel 
ODP‐50 (IPC)
MRM + [16]
MeTG‐XP, 
MeTI‐XP, 
TG‐XP, TI‐MP, 
TI‐TP
RBC LC‐MS/MS PP (heating, MetOH, 
CHCl3)
Biobasic AX (IXC) MRM + [13]
dFdC‐TP PBMC LC‐MS/MS PP (PCA) Biobasic AX (IXC) MRM − [17]
FUTP, FdUXP PBMC LC‐MS/MS PP (MetOH) Biobasic AX (IXC) MRM − [18]
TFV(XP), 
ZDV(XP), 
3TC(XP), 
FTC(XP)
RBC, PBMC LC‐MS/MS 
indirect
PP (70% MetOH), SPE, 
dephosphorylation, SPE
Synergi Polar RP 
(RP)
SRM + [14]
RBV(XP) RBC, PBMC, DBS LC‐MS/MS 
Indirect
PP (70% MetOH), SPE, 
dephosphorylation, SPE
Develosil C30‐ RP 
aqueous (RP)
SRM + [59]
ZDV(TP), 
3TC(TP)
PBMC LC‐MS/MS 
indirect
PP (70% MetOH), SPE, 
dephosphorylation, SPE
Hypersil C18 (RP) SRM + [22]
ddATP CEM‐T4cells LC‐MS/MS 
indirect
PP (70% MetOH), SPE, 
dephosphorylation, SPE
Purospher RP‐18e 
(RP)
SRM + [33]
Adefovir, 
Adefovir‐MP, 
Adefovir‐DP, 
Tenofovir‐DP, 
dATP
HepG2 LC‐MS/MS PP (70% MetOH) C18: Xterra/YMC 
/Luna
MRM + [28]
Table 2. Selected methods for determination of nucleotide analogues using mass spectrometry detection.
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nucleotides and nucleotide analogues in intracellular content [104, 107]. In this chapter, 
5‐ethynyl‐2′‐deoxyuridine (EdU) and its mono‐, di‐ and triphosphate analogues resulting 
from the incubation of cancerous cell lines with EdU and 5‐ethynyl‐2′‐deoxycytidine (EdC), 
together with endogenous purine and pyrimidine nucleotides, are presented.
7.2. Material and methods
7.2.1. Cell cultures
The cell line 143B PML BK TK [bone, osteosarcoma, contains a herpes simplex virus type 1 thy‐
midine kinase (hsv‐1 TK+) plasmid; 143B] was cultivated in DMEM supplemented with 3.7 gL−1 
of sodium bicarbonate and HAT (0.1 mM hypoxanthine, 400 nM aminopterin and 0.16 mM dT, 
Sigma Aldrich). The medium was also supplemented with 10% foetal bovine serum (Gibco) and 
50 μg mL−1 gentamicin. One week before the experiment, the culture medium was exchanged 
for a HAT‐free medium. For more details see the study by Ligasová et al. [108].
7.2.2. Chemicals
Water, acetonitrile, methanol, acetic acid, ammonium hydroxide (all LC‐MS purity grade), 
DMEM and dimethylsulphoxide (DMSO) were all purchased from Sigma Aldrich (St. Louis, 
MO, USA). 5‐Ethynyl‐2′‐deoxyuridine (EdU) was purchased from Carbosynth (Compton, 
Berkshire, United Kingdom) and 5‐ethynyl‐2′‐deoxycytidine (EdC) and EdU triphosphate 
(EdUTP) from Jena Biosciences (Jena, Germany). EdC monophosphate (EdCMP), EdC 
diphosphate (EdCDP) and EdC triphosphate (EdCTP) were synthesized by Dr. Liboska from 
the Institute of Organic Chemistry and Biochemistry, CAS, v.v.vi.
7.2.3. Instrumentation
Analyses of endogenous nucleosides, nucleotides, the nucleoside analogues and their phos‐
phorylated metabolites were performed using the Ultimate 3000 RS high‐performance liquid 
chromatographic system (Dionex, Sunnyvale, CA, USA) coupled with a Triple Quad 6500 
tandem mass spectrometer (Sciex, Framingham, MA, USA) equipped with an electrospray 
IonDrive Turbo V Source. A Luna NH
2
 aminopropyl column (2 × 100 mm, 3 μM, Phenomenex) 
protected by a 4 × 2‐mm ID guard column made of the same material (Phenomenex, Torrance, 
USA) was used for separation.
7.2.4. Sample preparation
The sample preparation of the cells treated with EdU or EdC is described previously in the 
study by Ligasová et al. [108]. Briefly, cells cultivated in a medium with or without nucleoside 
analogue for a definite time were immediately vacuum‐filtered. The membrane filter with 
the captured cells was transferred to a pre‐cooled Petri dish, extracted with a cold extraction 
solution (AcCN:MetOH:0.5 M FA/30:10:10), and returned to a −20°C freezer for 30 min. The 
filter was rinsed with the extraction solution in the dish, the solution was transferred into 
centrifuge microtubes, and then the filter was re‐rinsed with 1 mL of fresh cold extraction 
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solution, which was thereafter combined with the initial cell extract. After centrifugation, the 
supernatant was put into the freezer, pellet resuspended in fresh extraction solution, frozen 
and centrifuged, and the supernatant was combined with the previous one. The extract was 
neutralized with NH
4
HCO3 and centrifuged and the supernatant was lyophilized and resus‐pended in 100 μL of water mobile phase before the LC‐MS/MS analysis. All the procedures 
were performed in an ice bath to prevent undesirable metabolic processes in the cells during 
the sample preparation.
7.2.5. Standard stock solutions
Standard solutions of EdCMP, EdCDP, EdCTP and EdUTP were dissolved in deionized water 
in concentrations of 1.96, 3.6, 4.7 and 5 μM, respectively. EdU and EdC were dissolved in 
DMSO to a concentration of a 10‐mM stock solution. The working solutions of all standards 
for mass spectrometry optimization were obtained by serial dilutions to the required concen‐
trations with water of LC‐MS purity grade. All the solutions were stored at −80°C.
7.2.6. LC‐MS/MS analysis conditions
The separation and mass spectrometry method was previously described by Ligasová et 
al. [108]. Briefly, mobile phase A consisted of 20 mM ammonium acetate buffer solution, 
pH = 9.75, and mobile phase B was acetonitrile. The gradient elution program used for the 
separation started with 95% B and during 7 min was reduced to 10% B and held for the next 
7 min. Then, initial conditions were achieved in 1 min and equilibration took 3 min. The 
column was maintained at 35°C with a flow rate of 0.3 mL min−1. The total analysis time was 
17 min. The targeted metabolites were detected in multiple reaction monitoring (MRM) in 
both positive and negative electrospray ionization mode. The mass spectrometry parameters 
were optimized using a standard solution of the targeted analytes dissolved in a mixture 
of mobile phase A and B (50:50, v/v). The final MS conditions are summarized in Tables 3 
and 4 for positive and negative mode, respectively. Both quadrupoles (Q1 and Q3) were set 
to ‘unit’ resolution. The ion source parameters were optimized to the following settings: 
an ionization spray voltage of (−) 4500 V, a curtain gas of 30 psi, a collision gas of 8 psi, a 
heater gas and turbo ion spray gas of 40 psi, a source temperature of 400°C, and an entrance 
potential of (−) 10 V. High‐purity nitrogen was used as the collision gas. The Analyst 1.6.2 
and MultiQuant 3.0 software (Sciex, USA) were used for data acquisition and evaluation. 
Standards for EdUMP and EdUDP were not available and the mass spectrometry conditions 
were adopted from the optimization experiments of EdC/EdCMP/EdCDP/EdCTP. For more 
details, see the previously published study by Ligasová et al. [108].
7.3. Results and discussion
The first step in the mass spectrometry optimization was finding the optimal parameters for 
targeted metabolite analyses. Selected reaction monitoring (SRM) requires the accurate set‐
ting of molecular ion and the most sensitive and selective fragment, the optimal collision 
energy, declustering potential and entrance and exit potentials. A standard solution of each 
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ID Q1 Q3 DP CE ID Q1 Q3 DP CE ID Q1 Q3 DP CE
A 135.9 118.9 171 31 dHr 252.9 136.9 51 19 GMP 364.0 152.0 36 21
AMP 348.0 135.9 116 27 dUR 228.9 113.0 91 23 Gr 284.0 151.9 51 27
Ar 268.2 136.1 41 29 EdC 252.0 136.1 46 15 Hr 268.9 136.9 81 21
C 111.9 94.8 96 27 EdCDP 412.0 216.1 51 13 HX 136.9 109.9 136 29
CMP 323.8 111.9 46 21 EdCMP 332.0 136.1 36 17 IMP 349.0 136.9 31 19
Cr 244.0 111.9 31 27 EdCTP 491.9 136.1 71 19 T 126.9 109.9 96 23
dAMP 331.9 135.9 41 23 EdU 253.0 137.1 116 17 Tr 242.9 126.8 61 17
dAr 251.9 118.9 36 59 EdUMP 333.0 81.1 36 53 Xr 284.9 152.9 96 15
dCMP 307.9 112.0 56 19 EdUTP 492.9 81.0 111 55
dGMP 348.1 80.9 10 31 G 152.0 81.9 76 37
Table 3. MS parameters for targeted analytes in positive mode.
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ID Q1 Q3 DP CE ID Q1 Q3 DP CE ID Q1 Q3 DP CE
ADP 425.8 133.9 −95 −32 dTDP 400.8 158.8 −60 −34 EdUMP 331.0 135.0 −55 −26
ATP 506.1 159.0 −75 −30 dTMP 320.8 194.9 −35 −24 EdUTP 490.9 158.8 −70 −34
CDP 401.8 158.9 −60 −32 dTTP 480.7 158.8 −70 −46 GDP 441.8 158.8 −95 −36
CTP 481.7 158.9 −70 −44 dUMP 306.8 195.0 −50 −22 GTP 522.0 424.0 −90 −25
dADP 409.8 158.8 −30 −32 dUTP 466.7 158.9 −55 −36 IDP 426.8 134.9 −75 −32
dATP 489.7 158.7 −60 −36 EdC 249.9 136.0 −55 −12 ITP 506.7 158.7 −60 −48
dCDP 385.8 158.9 −30 −30 EdCDP 409.9 274.7 −45 −26 U 111.0 42.1 −35 −22
dCTP 465.7 158.9 −65 −36 EdCMP 329.9 194.8 −55 −22 UDP 402.9 158.8 −70 −34
dGDP 425.8 158.9 −70 −32 EdCTP 489.8 158.8 −5 −34 UMP 322.8 210.9 −65 −22
dGTP 506.1 159.0 −75 −30 EdU 250.9 134.8 −50 −16 UTP 482.7 158.7 −80 −48
dITP 490.7 158.8 −65 −40 EdUDP 411.0 78.9 −70 −102 X 150.9 108.0 −55 −24
Table 4. MS parameters for targeted analytes in negative mode.
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nucleotide was directly infused into the mass spectrometer and the parameters were tuned 
automatically. The most suitable ion for SRM was selected from the fragmentation spectra. 
The fragmentation spectra of EdU and EdUTP are shown in Figure 1. In positive mode, the 
cleavage of hydroxyl groups from deoxyribose (m/z of 235.0 and 217.2) and whole deoxyribose 
(137.0, 117.0 and 99.0) and cleavage of the pyrimidine ring (94.0) were typical fragmentation 
behaviour of EdU. In negative mode, the fragmentation is not so predictable and fragments 
of whole deoxyriboside (135.0) and the pyrimidine ring (207.8 and 92.0) and  deoxyriboside 
(160.8) were obtained. EdUTP was fragmented in positive mode, similarly to the cleavage 
of the pyrimidine ring (137.0 and 119.0), whole EdU without hydroxyl groups (217.2) and 
one terminal phosphate group (81.0), respectively. In negative mode, the fragmentation pat‐
tern of EdUTP contained cleavage in six different positions of the triphosphate group (79.0, 
97.0/393.0, 159.0, 176.8, 238.8 and 257.0) and the pyrimidine ring (135.0/355.0), respectively.
The fragmentation behaviour of deoxyriboside can be applied to other ribosides/deoxyribo‐
side and their analogues. The cleavage of sugar in both positive and negative ionization modes 
offers the most intensive product ion of the pyrimidine or purine ring, which is commonly 
used as a characteristic transition for SRM. Similarly, deoxy/nucleoside di‐ and triphosphates 
and their analogues offer the most intensive fragmentation in negative mode, with cleavage 
of one, two or three phosphates. The situation is different in the case of deoxy/nucleoside 
Figure 1. Fragmentation spectra of EdU and EdUTP in positive and negative ESI mode, respectively.
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monophosphates, which provide a more intensive signal in positive mode with cleavage of 
the purine or pyrimidine ring. This approach can be successfully applied for many different 
nucleosides or nucleotides even when standards are not commercially available. The other 
crucial parameter is the collision energy, which has to be carefully optimized. Again, it can be 
adopted from available standards during the compound tuning and optimization procedure. 
This general phenomenon is documented in Tables 3 and 4, which show the SRM transitions 
and other MS parameters of all the nucleotides included in the method.
For the separation and accurate determination of nucleotides, it is necessary to choose optimal 
conditions for the stationary and mobile phase, gradient program and flow rate. Nucleotides 
are very polar analytes, with a hydrophilic‐close‐to‐ionic character. Therefore, the analysis 
is not successful on common chromatography systems with reversed‐phase columns. Using 
HILIC separation mode based on aminopropyl or amidic stationary phases has advantages 
in the separation of many polar analytes with negatively charged functional groups, which 
are commonly present in biofluids or cell extracts. Moreover, analytes with a strong ionic 
character are retained even more. Typically, purine or pyrimidine analytes from bases up 
to nucleotide triphosphates can be separated in one analysis (Figures 2 and 3). The most 
important parameter for the separation is a pH with a value above 9.5, where triphosphates 
are not so strongly retained and the analysis time can be reduced to less than 20 min. The 
first general issue of using an aminopropyl column is the limited lifetime of the column (<400 
analyses), which can be overcome by using an amidic stationary phase (although the separa‐
tion behaviour is different). A second issue is the presence of significant ion suppression and 
lower sensitivity for more retained compounds which are eluted by the alkaline buffer in 
water. This can be overcome by using a thinner column with an inner diameter of 1 mm and 
by subsequently reducing the flow rate to 50 μL min−1 and by increasing the time taken for 
the analysis to 1 h.
The profiles of adenine, guanine, cytosine and uracil bases, ribosides and nucleotides in the 
cell line 143B incubated with EdU are shown in Figures 2 and 3. Purine bases, ribosides and 
monophosphates are most sensitive in positive ionization mode compared to di‐ and triphos‐
phates, which are significantly more ionizable in negative mode. On the contrary, the analysis 
of uracil and EdU and its nucleotides is more sensitive in negative mode for all the com‐
pounds. Three peaks in the range 7–12 min, corresponding to the electrospray fragmentation 
of nucleotides on bases, can be seen in a chromatogram of adenine SRM transition. Similarly, 
this phenomenon is also present in other chromatograms (AMP, ADP, GDP …). The new 
generation of triple quadrupoles brings the dynamic range of intensities up to seven orders, 
which is very useful for the multicomponent analysis of compounds with a large span of 
detector responses, such as biofluids. For example, adenosine has an intensity that is three 
orders higher compared to the uridine in the same sample. The disadvantage of the method is 
its inability to analyse isobaric compounds with the same separation behaviour: AMP/dGMP, 
ADP/dGDP and ATP/dGTP.
The cell line 143B was incubated with EdU and the corresponding nucleotides were followed. 
Because of the toxicity of EdU, the concentration in the incubation mixture was relatively 
low (10 μmol L−1) and therefore the production of nucleotides was limited to nmol‐μmol L−1 
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concentration levels. Figure 3 shows chromatograms of EdU and modified nucleotides in 
the intracellular extract of the incubated cell lines and controls without the addition of EdU. 
The optimization of the SRM transitions for commercially available EdU and EdUTP was 
performed. EdUMP and EdUDP were calculated theoretically and SRM transitions with 
 fragments of the pyrimidine base and one phosphate group for EdUMP and EdUDMP offered 
the most sensitive signal. The approximate concentrations of these two commercially unavail‐
able nucleotides were calculated from the ratio of the analogous SRM of the standards of 
adenine nucleotides.
7.4. Conclusion
Highly sensitive LC‐MS/MS method for determination of intracellular levels of nucleotide ana‐
logues EdU and EdC and its phosphorylated metabolites and several endogenous nucleotides 
was described. The use of aminopropyl column in HILIC adjustment enables efficient separa‐
tion of polar analytes during 17 min. Despite the limitations of the HILIC separation approach 
described above, it is very promising and probably the best way to analyse a wide range of 
Figure 2. Extracted SRM chromatograms of selected endogenous bases, ribosides and nucleotides in intracellular content 
of 143B cell line.
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purine and pyrimidine bases, ribosides and nucleotides within single analysis. Coupled with 
triple quadrupole mass spectrometry, it offers excellent selectivity and sensitivity, with a high 
linear response. Sample preparation based on cell lysis and protein precipitation by methanol 
without a need of SPE extraction allows application of the method on clinical studies. It can 
be applied on drug monitoring, pharmacokinetics studies and provides an insight into the 
influence of the nucleotide analogue on intracellular nucleotide pool in vitro.
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Abbreviations
Figure 3. Extracted SRM chromatograms of EdU, EdUMP, EdUDP and EdUTP in intracellular content of 143B cell line 
treated by EdU.
2cDA Chlorodeoxyadenosine/cladribine
3TC Lamivudine
AcCN Acetonitrile
ADP Adenosine diphosphate
AICA 5‐Aminoimidazole‐4‐carboxamide
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AMP Adenosine monophosphate
araC Cytarabine
araCMP Cytarabine monophosphate
araCTP Cytarabine triphosphate
ATP Adenosine triphosphate
AX Anion exchange
AZdU Azidodeoxyuridine
AZT Zidovudine
BrATP Bromoadenosine triphosphate
cAMP Cyclic adenosine monophosphate
CBV Carbovir
cCMP Cyclic cytidine monophosphate
CDP Cytidine diphosphate
CE Capillary electrophoresis
CEC Capillary electrochromatography
CGE Capillary gel electrophoresis
cGMP Cyclic guanosine monophosphate
CIEF Capillary isoelectric focusing
cIMP Cyclic inosine monophosphate
CoA Coenzyme A
CSF Cerebrospinal fluid
CTP Cytidine triphosphate
CU Chlorouracil
cUMP Cyclic uridine monophosphate
CZE Capillary zone electrophoresis
d4T Stavudine
dATP Deoxyadenosine triphosphate
dCTP Deoxycytidine triphosphate
ddA Dideoxyadenosine
ddAMP Dideoxyadenosine monophosphate
ddATP Dideoxyadenosine triphosphate
ddI Didanosine
ddN Dideoxynucleotides
DEA Diethylamine
dFdC Difluorodeoxycytidine/gemcitabine
dFdU Difluorodeoxyuridine
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dGTP Deoxyguanosine triphosphate
DMHA Dimethylhexylamine
DNA Deoxyribonucleic acid
DP Diphosphate/declustering potential
dTTP Deoxythymidine triphosphate
EdC Ethynyldeoxycytidine
EDTA Ethylenediaminetetraacetic acid
EOF Electro‐osmotic flow
ESI Electrospray ionization
EtOH Ethanol
FAD Flavinadeninedinucleotide
FdUMP Fluorodeoxyuridine monophosphate
FdUrd Fluorodeoxyuridine
FdUTP Fluorodeoxyuridine triphosphate
FLT 3′‐Deoxy‐3′‐fluorothymidine
FTC Emtricitabine
FU Fluorouracil
FUrd Fluorouridine
FUTP Fluorouridine triphosphate
GMP Guanosine monophosphate
GDP Guanosine diphosphate
GTP Guanosine triphosphate
HA Hexylamine
HFIP Hexafluoropropanol
HILIC Hydrophilic interaction liquid chromatography
HIV Human immunodeficiency virus
HPLC High‐performance liquid chromatography
CHO Chinese hamster ovarian
IDP Inosine diphosphate
IMP Inosine monophosphate
IP Ion‐pairing
IPC Ion‐pairing chromatography
ITP Isotachophoresis
IX Ion exchange
LC Liquid chromatography
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LLE Liquid‐liquid extraction
LLOQ Lower limit of quantification
MALDI‐TOF Matrix‐assisted laser desorption/ionization‐time of flight
MeCTP Methylcytidine triphosphate
MeGTP Methylguanosine triphosphate
MEKC Micellar electrokinetic chromatography
MeTI Methylthioinosine
MetOH Methanol
MeTG Methylthioguanosine
MP Monophosphate
MRM Multiple reaction monitoring
MS Mass spectrometry
MS/MS Tandem mass spectrometry
NAD Nicotinamide adenine dinucleotide
NADP Nicotinamide adenine dinucleotide phosphate
NHC N‐hydroxycytidine
NRTI Nucleotide reverse transcriptase inhibitor
NTPs Nucleotide triphosphates
PBMC Peripheral blood mononuclear cells
PBS Phosphate buffer saline
PCA Perchloric acid
PGC Porous graphitic carbon
PP Protein precipitation
RBC Red blood cells
RBV Ribavirin
RNA Ribonucleotide acid
RP Reversed phase
SPE Solid phase extraction
TBA Tetrabutylammonium
TCA Trichloroacetic acid
TDP Thymidine diphosphate
TEA Triethylamine CTP
TI Thioinosine
TFV Tenofovir
TG Thioguanosine
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